carvedilol has been researched along with bisoprolol in 195 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 10 (5.13) | 18.2507 |
| 2000's | 92 (47.18) | 29.6817 |
| 2010's | 81 (41.54) | 24.3611 |
| 2020's | 12 (6.15) | 2.80 |
| Authors | Studies |
|---|---|
| Topliss, JG; Yoshida, F | 1 |
| Baker, JG | 1 |
| Benz, RD; Contrera, JF; Kruhlak, NL; Matthews, EJ; Weaver, JL | 1 |
| Carrupt, PA; Guillarme, D; Henchoz, Y; Rudaz, S; Veuthey, JL | 1 |
| Lombardo, F; Obach, RS; Waters, NJ | 1 |
| Bard, B; Carrupt, PA; Martel, S | 1 |
| Chupka, J; El-Kattan, A; Feng, B; Miller, HR; Obach, RS; Troutman, MD; Varma, MV | 1 |
| Barnes, JC; Bradley, P; Day, NC; Fourches, D; Reed, JZ; Tropsha, A | 1 |
| Chang, G; El-Kattan, A; Miller, HR; Obach, RS; Rotter, C; Steyn, SJ; Troutman, MD; Varma, MV | 1 |
| Bellman, K; Knegtel, RM; Settimo, L | 1 |
| Chen, M; Hu, C; Suzuki, A; Thakkar, S; Tong, W; Yu, K | 1 |
| Chang, Q; Chen, Z; Hu, G; Hu, L; Li, Q; Long, J | 1 |
| De Cree, J; Geukens, H; Van Nueten, L; Verhaegen, H | 1 |
| Albrecht, M; Haustein, KO | 1 |
| Boccanelli, A; Camerini, F; Gavazzi, A; Gronda, E; Maggioni, AP; Opasich, C; Rapezzi, C; Scherillo, M; Sinagra, G; Tavazzi, L | 1 |
| Andréjak, M; Slama, M | 1 |
| Aiyar, N; Disa, J; Mitchell, MP; Naselsky, DP; Ohlstein, EH; Ruffolo, RR; Stadel, JM; Storer, BL; Willette, RN; Yue, TL | 1 |
| Carson, PE | 1 |
| Sasse, A; Schotten, U; vom Dahl, J | 1 |
| McMurray, JJ | 1 |
| Witkowska, M | 1 |
| Song, J; White, CM | 1 |
| Bristow, MR | 1 |
| Daniel, WG; Garlichs, C | 1 |
| Dunn, AB; Reddy, P | 1 |
| Goldstein, S; Gottlieb, SS | 1 |
| Frantz, RP | 1 |
| Chen, J; Christopher, TA; Gao, F; Gu, J; Lopez, BL; Lysko, P; Ma, XL; Ohlstein, EH; Ruffolo, RR; Yue, TL | 1 |
| Krum, H; Whorlow, SL | 1 |
| Spinar, J; Vítovec, J | 1 |
| Movahed, A | 1 |
| Chavey, WE | 1 |
| Hart, SM | 1 |
| Gregory, D; Konstam, MA; Udelson, JE | 1 |
| Varney, S | 1 |
| Lee, S; Spencer, A | 1 |
| Coutinho, J | 1 |
| Bölck, B; Brixius, K; Bundkirchen, A; Mehlhorn, U; Schwinger, RH | 1 |
| Czuriga, I; Edes, I | 1 |
| Ghanem, WM; Murin, J; Sleiman, OI | 1 |
| Adler, S; Kraatz, E; Kurz, T; Nötzold, A; Richardt, D; Richardt, G | 1 |
| Bobadilla, RV | 1 |
| Podbregar, M; Voga, G | 1 |
| Anker, SD; Von Haehling, S | 1 |
| Balli, E; Geraci, E; Gorini, M; Gronda, E; Lucci, D; Maggioni, AP; Opasich, C; Sinagra, G; Tavazzi, L; Tognoni, G | 1 |
| Blann, AD; Chin, BS; Gibbs, CR; Langford, NJ; Lip, GY; Nuttall, SL | 1 |
| Inoko, M; Nohara, R | 1 |
| Bouzamondo, A; Hulot, JS; Lechat, P; Sanchez, P | 1 |
| Blann, AD; Chin, BS; Gibbs, CR; Lip, GY | 1 |
| Goldstein, S; Sallach, JA | 1 |
| Anagnostopoulos, CE; Camm, AJ; Giazitzoglou, E; Karvouni, E; Katritsis, DG; Korovesis, S; Panagiotakos, DB; Paxinos, G | 1 |
| Al-Nasser, F; Bolger, AP | 1 |
| Francis, GS; Militello, M; Tang, WH | 1 |
| Gattis, W; Patel, MR | 1 |
| Harada, N; Isobe, H; Okajima, K; Uchiba, M | 1 |
| Adams, KF; Bristow, MR; Feldman, AM; Goldstein, S | 1 |
| Eschenhagen, T; Rau, T; Wuttke, H | 1 |
| Fukuchi, K; Hayashida, K; Ishida, Y; Kiso, K; Miyatake, K; Yasumura, Y | 1 |
| Bühring, K; Klein, W; Lamprecht, G; Lindner, W; Müller, F; Stoschitzky, G; Stoschitzky, K | 1 |
| Coffey, CS; Curtis, JP; Foody, JM; Hebert, PR; Ko, DT; Krumholz, HM; Sedrakyan, A | 1 |
| Di Lenarda, A; Sabbadini, G; Sinagra, G | 1 |
| Deray, G; Hulot, JS; Izzedine, H; Launay-Vacher, V; Sternberg, D | 1 |
| Atar, D; Galatius, S; Gustafsson, F; Hildebrandt, PR | 1 |
| Katritsis, DG | 1 |
| Bozhko, AA; Kanopskiĭ, SG; Staritskiĭ, AG | 1 |
| Jafri, SM | 1 |
| Rone, T; Sauls, JL | 1 |
| Murakami, T | 1 |
| Belousov, IuB; Khanina, NIu; Upnitskiĭ, AA | 1 |
| Angelini, A; Dalla Libera, L; Danieli Betto, D; Germinario, E; Gobbo, V; Ravara, B; Vescovo, G | 1 |
| Díez Manglano, J | 1 |
| Amouyel, P; Bauters, C; Dallongeville, J; de Groote, P; Foucher-Hossein, C; Helbecque, N; Hermant, X; Lamblin, N; Mc Fadden, E | 1 |
| Clark, AL; Cleland, JG; Nikitin, NP; Thackray, S; Witte, KK | 1 |
| Kowey, PR | 1 |
| Lechat, P; Ponikowski, P; van Veldhuisen, DJ; Willenheimer, R | 1 |
| Bian, WY; Duan, B; Jia, X; Li, W; Li, YS; Wang, F; Wang, L; Xu, ZM | 1 |
| Cohen-Solal, A; Dietz, R; Eichhorn, E; Erhardt, L; Hobbs, FD; Krum, H; Maggioni, A; McKelvie, RS; McMurray, J; Piña, IL; Soler-Soler, J; Swedberg, K | 1 |
| Altimir, S; Coll, R; Díez, C; González, B; Herreros, J; Lupón, J; Rey-Joly, C; Urrutia, A; Valle, V | 1 |
| Filipiak, KJ; Opolski, G | 1 |
| Auge, D; Bachmakov, I; Endress, B; Fromm, MF; Werner, U | 1 |
| Bonelli, C; Brussee, H; Dobnig, H; Stoschitzky, G; Stoschitzky, K | 1 |
| Champagne, J; Connolly, SJ; Dorian, P; Fain, E; Gent, M; Hohnloser, SH; Israel, CW; Roberts, R | 1 |
| Cai, Y; Jia, J; Li, S; Liu, G; Liu, Y; Pan, C; Ren, J; Yu, C | 1 |
| Chizyński, K; Goch, JH; Maciejewski, M; Ptaszyński, P; Ruta, J | 1 |
| Agostoni, P; Apostolo, A; Bussotti, M; Cattadori, G; Contini, M; Fiorentini, C; Palermo, P; Sciomer, S | 1 |
| Kawano, S | 1 |
| Gobec, L; Kovacić, D; Lainscak, M; Marinsek, M; Podbregar, M | 1 |
| Bauters, C; Dagorn, J; de Groote, P; Delour, P; Foucher-Hossein, C; Hennebert, O; Lamblin, N; Le Tourneau, T; Mouquet, F; Verkindère, C | 1 |
| Hua, C; Hua, L; Huang, J; Huang, Y; Jiang, W; Li, F; Li, N; Li, Y; Wang, F; Wu, Y; Xu, Z | 1 |
| Hamaad, A; Lip, GY; MacFadyen, RJ; Nicholls, D | 1 |
| Remme, WJ | 3 |
| Aronson, JK | 1 |
| Apostolović, S; Dietz, R; Düngen, HD; Edelmann, F; Eschenhagen, T; Follath, F; Gelbrich, G; Haverkamp, W; Inkrot, S; Krackhardt, F; Lainscak, M; Osterziel, KJ; Pavlović, M; Putniković, B; Rauchhaus, M; Tahirović, E; Waagstein, F; Wachter, R | 1 |
| Aygul, MU; Aygul, N; Duzenli, MA; Ozdemir, K | 1 |
| Beddies, G; Fox, PR; Kanikanti, VR; Keene, BW; Krebber, R; Papich, MD | 1 |
| Allen LaPointe, NM; Anstrom, KJ; Hernandez, AF; Kramer, JM; Stafford, JA; Zhou, Y | 1 |
| Adams, KF | 1 |
| Giles, TD | 1 |
| Archer, LD; Coppinger, T; Critchley, WR; Dunne, L; Fildes, JE; Shaw, SM; Waywell, C; Williams, SG; Yonan, N | 1 |
| Bakovic, D; Dujic, Z; Eterovic, D; Palada, I; Paukovic-Sekulic, B; Pivac, N; Valic, Z | 1 |
| Bachmakov, I; Endress, B; Fromm, MF; Glaeser, H; König, J; Mörl, F | 1 |
| Barroso, A; Bernáldez, MJ; Domingo, M; Domíngueza, M; Pie, M; Sancho, F; Simó, M; Verdú Rotellar, JM | 1 |
| Barratt, JD; Gilbert, AL; Killer, G; Peck, R; Pratt, N; Ramsay, E; Roughead, EE; Ryan, P | 1 |
| Hachiya, H; Haraguchi, G; Hirao, K; Inagaki, H; Isobe, M; Kawabata, M; Kimura, S; Konishi, M | 1 |
| Coleman, CF; Elsik, M; Hayward, CS; Jabbour, A; Keogh, AM; Kotlyar, E; Krum, H; Macdonald, PS; Mellemkjaer, S | 1 |
| Agostoni, P; Alimento, M; Apostolo, A; Bussotti, M; Cattadori, G; Cauti, FM; Contini, M; Farina, S; Magini, A; Magrì, D; Palermo, P; Salvioni, E; Sciomer, S; Vignati, C | 1 |
| Agostoni, P; Antonioli, L; Apostolo, A; Berna, G; Bussotti, M; Cattadori, G; Contini, M; Fiorentini, C; Palermo, P; Salvioni, E; Schina, M; Sciomer, S; Vignati, C | 1 |
| Cai, H; Chen, WQ; Ji, XP; Zhang, C; Zhang, Y | 1 |
| Lopes, CM; O-Uchi, J | 1 |
| Arisi, G; Caminiti, G; Iellamo, F; Madonna, M; Marazzi, G; Massaro, R; Righi, D; Rosano, GM; Volterrani, M | 1 |
| Anker, SD; Apostolovic, S; Dietz, R; Doehner, W; Düngen, HD; Edelmann, F; Eschenhagen, T; Gelbrich, G; Herrmann-Lingen, C; Inkrot, S; Krotin, M; Lainscak, M; Mehrhof, F; Neskovic, AN; Prettin, C; Putnikovic, B; Rau, T; Sakac, D; Tahirovic, E; Töpper, A; Waagstein, F; Wachter, R | 1 |
| Anker, SD; Apostolovic, S; Düngen, HD; Farkas, J; Gelbrich, G; Haverkamp, W; Herrmann-Lingen, C; Inkrot, S; Lainscak, M; Neskovic, AN; Rau, T; Tahirovic, E; Töpper, A | 1 |
| Haraguchi, G; Inagaki, H; Isobe, M; Kimura, S; Konishi, M; Yoshikawa, S | 1 |
| Seino, Y | 1 |
| Back, TG; Chen, H; Chen, J; Chen, SR; Chen, W; Cheng, H; Duff, HJ; Feldman, AM; Fill, M; Gillis, AM; Guo, A; Jiang, D; Jones, PP; Li, X; Smith, CD; Song, LS; Tian, X; Vembaiyan, K; Wang, A; Wang, R; Xiao, J; Xie, C; Yang, D; Zhang, J; Zhang, L; Zhong, X; Zhou, Q; Zhu, W | 1 |
| Kow, FP; Ong, HT | 1 |
| Lindenfeld, J; Page, RL; Rohrer, CK; Shakar, SF | 1 |
| Kovacic, D; Lainscak, M; Podbregar, M; Rozman, J; von Haehling, S | 1 |
| Anker, SD; Apostolovic, S; Dietz, R; Düngen, HD; Edelmann, F; Gelbrich, G; Inkrot, S; Lainscak, M; Loeffler, M; Neskovic, AN; Waagstein, F | 1 |
| Baulmann, J; Schunkert, H | 1 |
| Calori, G; De Cobelli, F; Del Maschio, A; Esposito, A; Fragasso, G; Lattuada, G; Locatelli, M; Maranta, F; Margonato, A; Perseghin, G; Scifo, P; Spoladore, R | 1 |
| Burrell, LM; Hare, DL; Kearney, LG; Ord, M; Srivastava, PM; Wai, B | 1 |
| Francis, GS; Sarraf, M | 1 |
| Cheng, XJ; He, YM; Li, X; Qian, YX; Xu, HF; Yang, XJ; Zhao, X | 1 |
| Onay-Besikci, A; Ozcelikay, AT; Suzmecelik, E | 1 |
| Apostolović, S; Dimković, S; Düngen, HD; Edelmann, F; Eschenhagen, T; Gelbrich, G; Haverkamp, W; Lainščak, M; Nešković, AN; Rau, T; Waagstein, F | 1 |
| Stiefelhagen, P | 1 |
| Colombo, P; Garan, AR; Hirsh, BJ; Jorde, UP; Mignatti, A; Sims, DB; Uriel, N | 1 |
| Benvenuto, A; Masciocco, L; Prencipe, G; Riccioni, G; Rizzo, U; Russi, C; Speziale, G; Ventra, S | 1 |
| Dekleva, M; Düngen, HD; Gelbrich, G; Incrot, S; Pavlovic Kleut, M; Suzic Lazic, J; Tahirovic, E; Waagstein, F | 1 |
| DiNicolantonio, JJ; Fares, H; Lavie, CJ; Menezes, AR; O'Keefe, JH | 1 |
| Antenore, A; Bagnoli, P; Dicembrini, I; Filippi, L; Mannucci, E; Marchionni, N; Monami, M; Rotella, CM; Sgrilli, F; Ungar, A | 1 |
| Apostolović, S; Düngen, HD; Edelmann, F; Haverkamp, W; Herrmann-Lingen, C; Inkrot, S; Lashki, DJ; Loncar, G; Neskovic, A; Scherer, M; Tahirović, E; Wachter, R | 1 |
| Agostoni, P; Alimento, M; Apostolo, A; Bertella, E; Cattadori, G; Contini, M; Farina, S; Fiorentini, C; Iorio, A; Karsten, M; Loguercio, M; Magrì, D; Mantegazza, V; Palermo, P; Paolillo, S; Salvioni, E; Sciomer, S | 1 |
| Asano, Y; Ichibori, Y; Kanzaki, M; Komuro, I; Minamiguchi, H; Mizote, I; Ohtani, T; Sakata, Y; Taniguchi, T | 1 |
| Mustafaev, II; Nurmamedova, GS | 1 |
| Hori, M; Izumi, T; Matsuzaki, M; Nagai, R | 1 |
| Díez-Manglano, J | 1 |
| Agostoni, P; Antonelli, A; Bovis, F; Contini, M; Gulotta, C; Iorio, A; Locatelli, A; Paolillo, S; Pellegrino, R; Salvioni, E; Torchio, R | 1 |
| Apostolovic, S; Djordjevic-Radojkovic, D; Düngen, HD; Gelbrich, G; Inkrot, S; Jankovic-Tomasevic, R; Lainscak, M; Musial-Bright, L; Pavlovic, M; Putnikovic, B; Radovanovic, S; Salinger-Martinovic, S; Stanojevic, D; Tahirovic, E; Tomasevic, M; Waagstein, F | 1 |
| Castagno, D; McMurray, JJ; Wedel, H; Wikstrand, J | 1 |
| Benvenuto, A; Buta, F; De Viti, D; Masciocco, L; Massari, F; Meliota, G; Riccioni, G; Saracino, P; Speziale, G | 1 |
| Balk, AH; Caliskan, K; Constantinescu, AA; Jewbali, L; Manintveld, OC; van Domburg, R | 1 |
| Hirano, K; Iida, O; Kawasaki, D; Miyashita, Y; Okazaki, S; Shinozaki, N; Shintani, Y; Soga, Y; Suematsu, N; Suzuki, K; Takahashi, H; Tsuchiya, T; Yamaoka, T | 1 |
| Hirata, K; Imanishi, J; Matsumoto, K; Miyoshi, T; Mochizuki, Y; Motoji, Y; Sawa, T; Tanaka, H; Tatsumi, K | 1 |
| Apostolović, S; Düngen, HD; Edelmann, F; Gelbrich, G; Inkrot, S; Krackhardt, F; Lainščak, M; Loncar, G; Musial-Bright, L; Sekularac, N; Störk, S; Tahirovic, E; Trippel, TD; Tscholl, V | 1 |
| Cho, MJ; Jung Kwak, M; Kim, HY; Kim, YM; Lee, HD; Lim, RK; Park, KH | 1 |
| Accogli, M; Ammendola, E; Bianchi, V; Calò, L; D'Onofrio, A; Del Giorno, G; Gronda, E; Malacrida, M; Palmisano, P; Rapacciuolo, A; Ruocco, A; Valsecchi, S | 1 |
| Andrey, JL; Aranda, RM; Garcia-Egido, A; Gomez, F; López-Sáez, JB; Pedrosa, MJ; Puerto, JL; Rosety, M | 1 |
| Asai, K; Furuse, E; Kubota, Y; Murai, K; Nakamura, S; Shimizu, W; Tsukada, YT | 1 |
| Andjelkovic, N; Davidovic, G; Djurdjevic, P; Ignjatovic, V; Ignjatovic, VD; Iric-Cupic, V; Jovanovic, D; Miloradovic, V; Nesic, J; Pavlovic, S; Petrovic, N; Simic, I; Simovic, S; Smiljanic, Z; Stolic, R; Zdravkovic, V | 1 |
| Ilashchuk, T; Okipniak, I; Shirokova, S | 1 |
| Bocchi, EA; Böhm, M; Borer, JS; Ford, I; Komajda, M; Swedberg, K; Tavazzi, L | 1 |
| Bahrudin, U; Endo, R; Hisatome, I; Ikeda, N; Inagaki, Y; Nakayama, Y; Ninomiya, H; Notsu, T; Onohara, T; Shirayoshi, Y; Surastri, B; Tanno, S; Yamaguchi, S; Yamamoto, K; Yoshida, A | 1 |
| Ahn, Y; Jeong, MH; Jin, HY; Kim, DI; Kim, DK; Kim, KH; Seo, GW; Seol, SH; Song, PS; Yang, TH | 1 |
| Amellone, C; Bianchi, V; Buja, G; Campari, M; Capucci, A; D'Onofrio, A; De Simone, A; Leoni, L; Morani, G; Stabile, G; Valsecchi, S | 1 |
| Chen, TH; Hong, CY; Sue, YM; Tang, CH; Wang, CC | 1 |
| Chang, YS; Chen, TJ; Chou, KT; Hu, YW; Hung, MH; Lee, FY; Liu, CJ; Ou, SM; Perng, DW; Su, VY; Yang, KY | 1 |
| Fi, Z; Szentes, V | 1 |
| Bueno, H; Escoda, R; Gil, V; Herrero, P; Jacob, J; Llorens, P; Martín-Sánchez, FJ; Mebazaa, A; Miró, Ò; Müller, C | 1 |
| Bouvier, M; de Denus, S; Deblois, D; Dorais, M; Dubé, MP; Haibe-Kains, B; Jenna, S; Leduc, R; Perreault, S; Rouleau, JL; Tardif, JC; White, M; White-Guay, B | 1 |
| Chen, CY; Huang, YB; Lin, TY | 1 |
| Chen, RJ; Chu, H; Tsai, LW | 1 |
| Komal, C; Prachi, S; Priti, MJ | 1 |
| Apostolovic, S; Chavanon, ML; Düngen, HD; Herrmann-Lingen, C; Inkrot, S; Lainscak, M; Loncar, G; Matic, D; Pieske, B; Ristic, AD; Sljivic, A; Stanojevic, D; Tahirovic, E; Veskovic, J; Zdravkovic, M; Zelenak, C | 1 |
| Agewall, S; Atar, D; Clark, AL; Cleland, JGF; Corletto, A; Frankenstein, L; Fröhlich, H; Goode, K; Grundtvig, M; Hole, T; Katus, HA; Kazmi, S; Schellberg, D; Täger, T; Torres, L | 1 |
| Fujito, K; Kimura, K; Takayanagi, R; Yamada, Y | 1 |
| Bhushan, R; Malik, P | 1 |
| Chen, CY; Huang, YB; Kuo, CC; Liao, KM; Lin, TY | 1 |
| Andersen, MP; Capuano, A; Enghusen-Poulsen, H; Gislason, G; Mascolo, A; Mortensen, RN; Rosano, GMC; Rossi, F; Sessa, M; Torp-Pedersen, C | 1 |
| Ingram, A; Valente, M | 1 |
| Addison, D; Alam, M; Jneid, H; Kayani, W; Lakkis, N; Misra, A; Pham, D; Resar, J | 1 |
| Baek, SH; Chae, SC; Cho, MC; Choi, DJ; Choi, JO; Choi, KH; Jeon, ES; Kang, SM; Kim, JJ; Kim, KH; Lee, GY; Lee, HY; Lee, SE; Oh, BH; Park, HY; Yoo, BS | 1 |
| Brown, TM; Chen, L; Durant, RW; Kilgore, ML; Levitan, EB; Loop, MS; Safford, MM; van Dyke, MK | 1 |
| Baek, SH; Chae, SC; Cho, HJ; Cho, MC; Choi, DJ; Jeon, ES; Kang, SM; Kim, JJ; Kim, KH; Lee, HY; Oh, BH; Park, HA; Park, JJ; Yoo, BS | 1 |
| Busjahn, A; Dechend, R; Dragun, D; Dungen, HD; Edelmann, F; Heidecke, H; Junker, J; Mueller, DN; Obradovic, D; Pieske, B; Riemekasten, G; Tahirovic, E; Trippel, TD; Wilck, N | 1 |
| Fujii, E; Kishi, T | 1 |
| Kinugawa, S; Komuro, I; Masuyama, T; Momomura, SI; Murohara, T; Saito, Y; Tsutsui, H | 1 |
| Andersen, M; Capuano, A; Jensen, MT; Kragholm, K; Mascolo, A; Pagliaro, C; Rafaniello, C; Rasmussen, DB; Rossi, F; Sessa, M; Sportiello, L; Tari, GM | 1 |
| Abe, S; Arikawa, T; Haruyama, A; Inami, S; Inoue, T; Nakajima, T; Node, K; Saito, F; Sakuma, M; Tanaka, A; Toyoda, S; Watanabe, R | 1 |
| Andrews, LM; Koch, BCP; van der Nagel, BCH; van Domburg, B | 1 |
| Jacobsen, SJ; Kalantar-Zadeh, K; Kovesdy, CP; Lee, MS; Neyer, JR; Shaw, SF; Shi, J; Sim, JJ; Zhou, H | 1 |
| Aiglova, R; Danek, J; Gloger, V; Lazarova, M; Pavlu, L; Precek, J; Schee, A; Skala, T; Taborsky, M; Vicha, M | 1 |
| Appunni, S; Blaschke, F; Düngen, HD; Edelmann, F; Lacour, P; Loncar, G; McGranaghan, P; Obradovic, D; Pieske, B; Rubens, M; Salami, J; Saxena, A; Tahirovic, E; Trippel, TD; Veledar, E | 1 |
| Koraćević, G; Koraćević, M; Kostić, T; Lović, D; Mićić, S; Pavlović, D; Stojanović, M; Zdravković, M | 1 |
| Agostoni, P; Contini, M; Rovai, S; Sciomer, S; Vignati, C | 1 |
| Higashizawa, T; Hisatake, Y; Kitagawa, K; Kondo, M; Noda, M; Okamura, Y; Sekine, C; Sunaga, S; Teramoto, K | 1 |
| Blecker, SB; Dunlay, SM; Killian, JM; Redfield, MM; Roger, VL; Savitz, ST; Schulte, PJ | 1 |
| Kawasaki, N; Mizuno, Y; Nishida, K; Ogata, F; Uematsu, Y | 1 |
| Frey, N; Gampp, H; Hackbarth, J; Lugenbiel, P; Müller, ME; Petersenn, F; Pfeiffer, J; Rahm, AK; Rivinius, R; Thomas, D | 1 |
44 review(s) available for carvedilol and bisoprolol
| Article | Year |
|---|---|
DILIrank: the largest reference drug list ranked by the risk for developing drug-induced liver injury in humans.
Topics: Chemical and Drug Induced Liver Injury; Databases, Factual; Drug Labeling; Humans; Pharmaceutical Preparations; Risk | 2016 |
[Beta blockers in heart failure. Experiences and recommendations for clinical use. ANMCO-Area Heart Failure].
Topics: Adrenergic beta-Antagonists; Aged; Bisoprolol; Carbazoles; Carvedilol; Controlled Clinical Trials as Topic; Follow-Up Studies; Heart Failure; Humans; Metoprolol; Propanolamines; Prospective Studies; Randomized Controlled Trials as Topic; Time Factors; Vasodilator Agents | 1998 |
Beta-blocker therapy in heart failure: pathophysiology and clinical results.
Topics: Adrenergic beta-Antagonists; Aged; Bisoprolol; Carbazoles; Carvedilol; Clinical Trials as Topic; Exercise; Heart Failure; Heart Rate; Hemodynamics; Humans; Imidazoles; Male; Metoprolol; Middle Aged; Propanolamines; Propranolol; Quality of Life; Stroke Volume; Time Factors; Vasodilator Agents; Xamoterol | 1999 |
[Drug therapy of chronic heart failure: when are beta receptor blockers indicated?].
Topics: Adrenergic beta-Antagonists; Anti-Arrhythmia Agents; Antihypertensive Agents; Bisoprolol; Carbazoles; Carvedilol; Chronic Disease; Heart Failure; Hemodynamics; Humans; Meta-Analysis as Topic; Metoprolol; Placebos; Propanolamines; Randomized Controlled Trials as Topic; Risk Factors; Time Factors | 1999 |
Major beta blocker mortality trials in chronic heart failure: a critical review.
Topics: Adrenergic beta-Antagonists; Aged; Aged, 80 and over; Bisoprolol; Carbazoles; Carvedilol; Female; Heart Failure; Humans; Male; Metoprolol; Morbidity; Multicenter Studies as Topic; Propanolamines; Prospective Studies; Randomized Controlled Trials as Topic; Ventricular Dysfunction, Left | 1999 |
Beta-adrenoceptor blockers in heart failure.
Topics: Adrenergic beta-Antagonists; Bisoprolol; Carbazoles; Carvedilol; Heart Failure; Humans; Metoprolol; Propanolamines; Treatment Outcome | 1999 |
beta-adrenergic receptor blockade in chronic heart failure.
Topics: Adrenergic beta-Antagonists; Bisoprolol; Carbazoles; Carvedilol; Chronic Disease; Heart Failure; Heart Function Tests; Humans; Metoprolol; Propanolamines; Receptors, Adrenergic, beta; Signal Transduction | 2000 |
The effect of beta-blockers on health-related quality of life in patients with heart failure.
Topics: Adrenergic beta-Antagonists; Bisoprolol; Carbazoles; Carvedilol; Clinical Trials as Topic; Health Status; Heart Failure; Humans; Metoprolol; Propanolamines; Quality of Life | 2000 |
The impact of beta-blockade on mortality rates in patients with congestive heart failure.
Topics: Adrenergic beta-Antagonists; Bisoprolol; Carbazoles; Carvedilol; Heart Failure; Humans; Meta-Analysis as Topic; Metoprolol; Patient Selection; Propanolamines; Randomized Controlled Trials as Topic; Risk Factors; Survival Analysis; Treatment Outcome | 2000 |
Beta blockade in patients with congestive heart failure. Why, who, and how.
Topics: Adrenergic beta-Antagonists; Bisoprolol; Carbazoles; Carvedilol; Contraindications; Heart Failure; Humans; Metoprolol; Patient Selection; Propanolamines; Ventricular Dysfunction, Left | 2000 |
Meta-analysis of effect of beta-blocker therapy on mortality in patients with New York Heart Association class IV chronic congestive heart failure.
Topics: Adrenergic beta-Antagonists; Benzopyrans; Bisoprolol; Carbazoles; Carvedilol; Ethanolamines; Heart Failure; Humans; Metoprolol; Nebivolol; Propanolamines | 2000 |
Beta blockers and congestive heart failure.
Topics: Adrenergic beta-Antagonists; Bisoprolol; Carbazoles; Carvedilol; Heart Failure; Humans; Meta-Analysis as Topic; Metoprolol; Propanolamines; Randomized Controlled Trials as Topic; Risk; Severity of Illness Index; Stroke Volume; Systole; Treatment Outcome | 2000 |
The importance of beta blockers in the treatment of heart failure.
Topics: Adrenergic beta-Antagonists; Bisoprolol; Carbazoles; Carvedilol; Contraindications; Drug Administration Schedule; Female; Heart Failure; Humans; Male; Metoprolol; Patient Selection; Propanolamines; Randomized Controlled Trials as Topic; Severity of Illness Index | 2000 |
Influence of beta-blockers on mortality in chronic heart failure.
Topics: Adrenergic beta-Antagonists; Bisoprolol; Carbazoles; Carvedilol; Chronic Disease; Heart Failure; Humans; Metoprolol; Morbidity; Propanolamines; Randomized Controlled Trials as Topic; Treatment Outcome | 2000 |
Economic impact of beta blockade in heart failure.
Topics: Adrenergic beta-Antagonists; Bisoprolol; Carbazoles; Carvedilol; Clinical Trials as Topic; Cost-Benefit Analysis; Drug Costs; Heart Failure; Humans; Metoprolol; Models, Economic; Propanolamines; Sensitivity and Specificity; United States | 2001 |
Beta-blockers to reduce mortality in patients with systolic dysfunction: a meta-analysis.
Topics: Adrenergic beta-Antagonists; Bisoprolol; Carbazoles; Carvedilol; Heart Failure; Hemodynamics; Humans; Metoprolol; Propanolamines; Research Design; Risk Factors; Severity of Illness Index; Systole; Treatment Outcome | 2001 |
[Adrenergic beta inhibitors in heart insufficiency: which and when?].
Topics: Adrenergic beta-Antagonists; Bisoprolol; Carbazoles; Carvedilol; Heart Failure; Humans; Metoprolol; Patient Selection; Propanolamines; Randomized Controlled Trials as Topic; Sympathetic Nervous System; Ventricular Dysfunction, Left | 2001 |
[Role of beta-blockers in the treatment of chronic heart heart failure].
Topics: Adrenergic beta-Antagonists; Bisoprolol; Carbazoles; Carvedilol; Chronic Disease; Controlled Clinical Trials as Topic; Disease Progression; Drug Administration Schedule; Heart Failure; Humans; Metoprolol; Myocardial Contraction; Patient Selection; Propanolamines; Survival Rate; Ventricular Dysfunction, Left; Ventricular Function, Left | 2001 |
Beta-blockers in heart failure.
Topics: Adrenergic beta-Antagonists; Bisoprolol; Carbazoles; Carvedilol; Heart Failure; Humans; Metoprolol; Propanolamines | 2001 |
[Use of beta-blockers in heart failure].
Topics: Adrenergic beta-Antagonists; Bisoprolol; Carbazoles; Carvedilol; Clinical Trials as Topic; Contraindications; Heart Failure; Humans; Metoprolol; Propanolamines | 2003 |
Beta-blocker benefit according to severity of heart failure.
Topics: Adrenergic beta-Antagonists; Bisoprolol; Carbazoles; Carvedilol; Chronic Disease; Heart Failure; Hospitalization; Humans; Metoprolol; Propanolamines; Risk Assessment; Risk Factors; Severity of Illness Index; Stroke Volume; Survival Analysis; Treatment Outcome | 2003 |
Use of beta-blockers in congestive heart failure.
Topics: Adrenergic beta-Antagonists; Bisoprolol; Carbazoles; Carvedilol; Dose-Response Relationship, Drug; Forecasting; Heart Failure; Humans; Metoprolol; Propanolamines; Randomized Controlled Trials as Topic | 2003 |
Beta-blockers for chronic heart failure: surviving longer but feeling better?
Topics: Adrenergic beta-Antagonists; Bisoprolol; Carbazoles; Carvedilol; Exercise Test; Exercise Tolerance; Heart Failure; Humans; Metoprolol; Propanolamines; Quality of Life | 2003 |
Selective versus nonselective beta-blockade for heart failure therapy: are there lessons to be learned from the COMET trial?
Topics: Adrenergic beta-Antagonists; Bisoprolol; Carbazoles; Carvedilol; Dose-Response Relationship, Drug; Europe; Heart Failure; Humans; Metoprolol; Propanolamines; Receptors, Adrenergic, beta-1; Risk Factors; Sympathetic Nervous System; Ventricular Dysfunction, Left | 2003 |
[Genetic polymorphisms in drug metabolizing enzymes--impact on treatment with beta-blockers].
Topics: Adrenergic alpha-Antagonists; Adrenergic beta-Antagonists; Alleles; Atenolol; Benzopyrans; Biotransformation; Bisoprolol; Carbazoles; Carvedilol; Clinical Trials as Topic; Cytochrome P-450 CYP2D6; Ethanolamines; Female; Genotype; Humans; Male; Metoprolol; Mutation; Nebivolol; Pharmacogenetics; Phenotype; Polymorphism, Genetic; Propanolamines; Risk Factors; Time Factors | 2004 |
The effects of beta blockers on morbidity and mortality in heart failure.
Topics: Adrenergic beta-Antagonists; Bisoprolol; Carbazoles; Carvedilol; Heart Failure; Humans; Metoprolol; Morbidity; Multicenter Studies as Topic; Propanolamines; Randomized Controlled Trials as Topic; Survival Analysis; United States | 2004 |
Emerging trends in the management of heart failure: Beta blocker therapy.
Topics: Adrenergic beta-Antagonists; Angiotensin-Converting Enzyme Inhibitors; Bisoprolol; Carbazoles; Carvedilol; Clinical Trials as Topic; Cost of Illness; Diuretics; Drug Costs; Drug Therapy, Combination; Heart Failure; Humans; Metoprolol; Morbidity; Natriuretic Peptides; Nurse's Role; Patient Selection; Practice Guidelines as Topic; Propanolamines; Quality of Life; Renin-Angiotensin System; Severity of Illness Index; Sympathetic Nervous System; Treatment Outcome | 2005 |
[Beta blockers for therapy of chronic heart failure].
Topics: Adrenergic beta-Antagonists; Bisoprolol; Carbazoles; Carvedilol; Chronic Disease; Clinical Trials as Topic; Heart Failure; Humans; Metoprolol; Propanolamines | 2005 |
[Congestive heart failure in Spain: cost-effectiveness and cost-benefit analyses of treatment with beta-blockers].
Topics: Adrenergic beta-Antagonists; Bisoprolol; Carbazoles; Carvedilol; Cost-Benefit Analysis; Heart Failure; Humans; Metoprolol; Propanolamines; Randomized Controlled Trials as Topic; Spain | 2005 |
A review of carvedilol arrhythmia data in clinical trials.
Topics: Adrenergic beta-Antagonists; Amiodarone; Anti-Arrhythmia Agents; Atrial Fibrillation; Bisoprolol; Carbazoles; Carvedilol; Death, Sudden, Cardiac; Digoxin; Heart Failure; Humans; Metoprolol; Myocardial Infarction; Propanolamines; Randomized Controlled Trials as Topic | 2005 |
[Beta-adrenolytics in heart failure--are they all really equal?].
Topics: Adrenergic beta-Antagonists; Bisoprolol; Carbazoles; Carvedilol; Heart Failure; Humans; Metoprolol; Propanolamines | 2005 |
[Beta blockers: characteristics, mechanisms of action, pharmacokinetics, indication, contraindication, clinical data, and side effects].
Topics: Adrenergic beta-Antagonists; Bisoprolol; Carbazoles; Carvedilol; Clinical Trials as Topic; Contraindications; Heart Failure; Humans; Metoprolol; Propanolamines | 2007 |
Beta blockers or angiotensin-converting-enzyme inhibitor/angiotensin receptor blocker: what should be first?
Topics: Adrenergic beta-Antagonists; Angiotensin-Converting Enzyme Inhibitors; Bisoprolol; Carbazoles; Carvedilol; Defibrillators, Implantable; Disease Progression; Enalapril; Heart Failure; Humans; Perindopril; Propanolamines; Treatment Outcome; Ventricular Remodeling | 2007 |
Beta-blockers in heart failure: how far have we progressed?
Topics: Adrenergic beta-Antagonists; Antihypertensive Agents; Bisoprolol; Carbazoles; Carvedilol; Contraindications; Heart Failure; Humans; Metoprolol; Propanolamines; Sympathetic Nervous System; Ventricular Dysfunction, Left | 2002 |
Use of beta-blockers for heart failure in patients with diabetes mellitus.
Topics: Adrenergic beta-Antagonists; Antihypertensive Agents; Bisoprolol; Carbazoles; Carvedilol; Diabetes Complications; Diabetes Mellitus; Heart Failure; Humans; Metoprolol; Propanolamines; United States | 2002 |
β-blockers in stage B: a precursor of heart failure.
Topics: Adrenergic beta-Antagonists; Animals; Benzazepines; Bisoprolol; Carbazoles; Cardiovascular System; Carvedilol; Disease Progression; Heart Failure; Heart Ventricles; Humans; Ivabradine; Propanolamines; Sympathetic Nervous System; Ventricular Dysfunction, Left | 2012 |
β-Blockers in heart failure: benefits of β-blockers according to varying male proportions of study patients.
Topics: Adrenergic beta-Antagonists; Antihypertensive Agents; Bisoprolol; Carbazoles; Carvedilol; China; Heart Failure; Hospitalization; Humans; Male; Metoprolol; Propanolamines; Statistics as Topic; Vasodilator Agents | 2012 |
Meta-analysis of carvedilol versus beta 1 selective beta-blockers (atenolol, bisoprolol, metoprolol, and nebivolol).
Topics: Adrenergic beta-1 Receptor Antagonists; Atenolol; Benzopyrans; Bisoprolol; Carbazoles; Carvedilol; Ethanolamines; Global Health; Humans; Metoprolol; Myocardial Infarction; Nebivolol; Platelet Aggregation Inhibitors; Propanolamines; Survival Rate; Treatment Outcome | 2013 |
Further data on beta-blockers and cancer risk: observational study and meta-analysis of randomized clinical trials.
Topics: Adrenergic beta-Antagonists; Aged; Atenolol; Benzopyrans; Bisoprolol; Carbazoles; Carvedilol; Diabetes Mellitus; Ethanolamines; Female; Humans; Insulin; Insulin Glargine; Insulin, Long-Acting; Male; Metformin; Myocardial Ischemia; Nebivolol; Neoplasms; Propanolamines; Risk | 2013 |
Effects of beta-blockers for congestive heart failure in pediatric and congenital heart disease patients: a meta-analysis of published studies.
Topics: Adrenergic beta-Antagonists; Age Factors; Bisoprolol; Carbazoles; Carvedilol; Child; Heart Defects, Congenital; Heart Failure; Humans; Metoprolol; Propanolamines; Ventricular Dysfunction, Left | 2015 |
[The benefits of carvedilol therapy in the treatment of patients with high cardiovascular risk].
Topics: Adrenergic beta-Antagonists; Angina Pectoris; Antihypertensive Agents; Bisoprolol; Carbazoles; Cardiovascular Diseases; Carvedilol; Clinical Trials as Topic; Drug Prescriptions; Evidence-Based Medicine; Heart Failure; Hemodynamics; Humans; Hungary; Hypertension; Metoprolol; Multicenter Studies as Topic; Oxidative Stress; Primary Health Care; Propanolamines; Risk | 2016 |
Genetic Variation of Hepatic Enzymes Influence on β-Blocker Dose in Patients With Reduced Ejection Fraction Heart Failure.
Topics: Adrenergic beta-Antagonists; Bisoprolol; Carvedilol; Cytochrome P-450 CYP2D6; Genetic Variation; Heart Failure; Humans; Metoprolol; Research Design; Treatment Outcome | 2020 |
Outcomes of beta blocker use in cocaine-associated chest pain: a meta-analysis.
Topics: Acute Coronary Syndrome; Adrenergic beta-Antagonists; Atenolol; Bisoprolol; Carvedilol; Cocaine; Humans; Metoprolol; Propanolamines; Propranolol | 2018 |
Carvedilol and bisoprolol as initial therapy for adult hypertension without compelling indications.
Topics: Antihypertensive Agents; Bisoprolol; Blood Pressure; Carvedilol; Humans; Hypertension; Treatment Outcome | 2019 |
52 trial(s) available for carvedilol and bisoprolol
| Article | Year |
|---|---|
Comparative cardiac haemodynamics of bisoprolol, celiprolol, carvedilol and nebivolol in normal volunteers.
Topics: Adrenergic beta-Antagonists; Adult; Benzopyrans; Bisoprolol; Carbazoles; Carvedilol; Celiprolol; Electrocardiography; Ethanolamines; Hemodynamics; Humans; Male; Middle Aged; Myocardial Contraction; Nebivolol; Propanolamines; Ventricular Function, Left | 1992 |
Effect of selective and nonselective beta-blockers on resting energy production rate and total body substrate utilization in chronic heart failure.
Topics: Adipose Tissue; Adrenergic beta-Antagonists; Aged; Basal Metabolism; Bisoprolol; Blood Pressure; Body Weight; Carbazoles; Carvedilol; Chronic Disease; Epinephrine; Female; Heart Failure; Heart Rate; Humans; Male; Middle Aged; Norepinephrine; Patient Compliance; Propanolamines; Severity of Illness Index; Statistics as Topic; Stroke Volume; Treatment Outcome; Uric Acid; Ventricular Dysfunction, Left | 2002 |
Beta-blocker benefit according to severity of heart failure.
Topics: Adrenergic beta-Antagonists; Bisoprolol; Carbazoles; Carvedilol; Chronic Disease; Heart Failure; Hospitalization; Humans; Metoprolol; Propanolamines; Risk Assessment; Risk Factors; Severity of Illness Index; Stroke Volume; Survival Analysis; Treatment Outcome | 2003 |
Comparison of effectiveness of carvedilol versus bisoprolol for maintenance of sinus rhythm after cardioversion of persistent atrial fibrillation.
Topics: Adrenergic beta-Antagonists; Aged; Atrial Fibrillation; Bisoprolol; Carbazoles; Carvedilol; Double-Blind Method; Electric Countershock; Female; Follow-Up Studies; Humans; Male; Middle Aged; Propanolamines; Secondary Prevention; Time Factors; Treatment Outcome | 2003 |
Gated myocardial SPECT to predict response to beta-blocker therapy in patients with idiopathic dilated cardiomyopathy.
Topics: Adrenergic beta-Antagonists; Adult; Age Factors; Aged; Bisoprolol; Carbazoles; Cardiomyopathy, Dilated; Carvedilol; Drug Therapy, Combination; Feasibility Studies; Female; Gated Blood-Pool Imaging; Humans; Male; Middle Aged; Prognosis; Propanolamines; Reproducibility of Results; Risk Assessment; Sensitivity and Specificity; Sex Factors; Tomography, Emission-Computed, Single-Photon; Treatment Outcome; Ventricular Dysfunction, Left | 2004 |
Different effects of exercise on plasma concentrations of nebivolol, bisoprolol and carvedilol.
Topics: Administration, Oral; Adrenergic beta-Antagonists; Adult; Benzopyrans; Bisoprolol; Carbazoles; Carvedilol; Cross-Over Studies; Ethanolamines; Exercise; Humans; Male; Nebivolol; Propanolamines; Rest | 2004 |
Adverse effects of beta-blocker therapy for patients with heart failure: a quantitative overview of randomized trials.
Topics: Adrenergic beta-Antagonists; Aged; Bisoprolol; Bradycardia; Carbazoles; Carvedilol; Dizziness; Fatigue; Female; Follow-Up Studies; Heart Conduction System; Heart Failure; Humans; Hypotension; Male; Metoprolol; Middle Aged; Propanolamines; Risk Factors; Risk Reduction Behavior; Severity of Illness Index; Statistics as Topic; Treatment Failure; Ventricular Dysfunction, Left; Withholding Treatment | 2004 |
Tolerability of beta-blocker initiation and titration with bisoprolol and carvedilol in congestive heart failure -- a randomized comparison.
Topics: Adrenergic beta-Antagonists; Aged; Bisoprolol; Carbazoles; Carvedilol; Drug Administration Schedule; Female; Heart Failure; Humans; Male; Maximum Tolerated Dose; Propanolamines; Prospective Studies; Treatment Outcome | 2004 |
[Effect of long-term therapy with contemporary drugs on diastolic cardiac function in patients with chronic heart failure].
Topics: Adrenergic beta-Antagonists; Angiotensin-Converting Enzyme Inhibitors; Bisoprolol; Carbazoles; Carvedilol; Diastole; Double-Blind Method; Drug Therapy, Combination; Echocardiography, Doppler; Enalapril; Follow-Up Studies; Heart Failure; Humans; Middle Aged; Myocardial Contraction; Propanolamines; Time Factors; Treatment Outcome; Ventricular Function, Left | 2005 |
[Beneficial neurohormonal profiles of beta-blockades in chronic left heart failure].
Topics: Adolescent; Adrenergic beta-Antagonists; Adult; Aged; Aged, 80 and over; Bisoprolol; Carbazoles; Carvedilol; Chronic Disease; Female; Heart Failure; Humans; Male; Middle Aged; Natriuretic Peptide, Brain; Peptide Fragments; Prognosis; Propanolamines; Sensitivity and Specificity; Ventricular Function, Left | 2005 |
Comparing beta-blocking effects of bisoprolol, carvedilol and nebivolol.
Topics: Adrenergic beta-Antagonists; Adult; Benzopyrans; Bisoprolol; Blood Pressure; Carbazoles; Carvedilol; Circadian Rhythm; Cross-Over Studies; Double-Blind Method; Ethanolamines; Exercise; Heart Rate; Humans; Male; Melatonin; Nebivolol; Placebos; Propanolamines; Quality of Life; Rest; Sleep | 2006 |
Effect of amiodarone and sotalol on ventricular defibrillation threshold: the optimal pharmacological therapy in cardioverter defibrillator patients (OPTIC) trial.
Topics: Adrenergic beta-Antagonists; Aged; Amiodarone; Anti-Arrhythmia Agents; Atrial Fibrillation; Bisoprolol; Carbazoles; Carvedilol; Combined Modality Therapy; Defibrillators, Implantable; Female; Heart Arrest; Humans; Male; Metoprolol; Middle Aged; Myocardial Infarction; Propanolamines; Sotalol; Ventricular Fibrillation; Ventricular Function, Left | 2006 |
[Effect of low doses of metoprolol, bisoprolol and carvedilol on mortality in patients with left ventricular dysfunction after acute myocardial infarction].
Topics: Acute Disease; Adrenergic beta-Antagonists; Adult; Aged; Angioplasty, Balloon, Coronary; Bisoprolol; Carbazoles; Carvedilol; Dose-Response Relationship, Drug; Female; Humans; Male; Metoprolol; Middle Aged; Myocardial Infarction; Propanolamines; Retrospective Studies; Stroke Volume; Treatment Outcome; Ventricular Dysfunction, Left | 2006 |
Lung function with carvedilol and bisoprolol in chronic heart failure: is beta selectivity relevant?
Topics: Adrenergic beta-Antagonists; Aged; Bisoprolol; Carbazoles; Carvedilol; Chronic Disease; Cross-Over Studies; Double-Blind Method; Exercise; Female; Heart Failure; Hemodynamics; Humans; Lung; Male; Middle Aged; Oxygen Consumption; Propanolamines; Pulmonary Diffusing Capacity; Respiratory Function Tests | 2007 |
Effect of selective and non-selective beta-blockers on body weight, insulin resistance and leptin concentration in chronic heart failure.
Topics: Adrenergic beta-Antagonists; Aged; Bisoprolol; Blood Glucose; Body Weight; Carbazoles; Carvedilol; Chronic Disease; Female; Heart Failure; Homeostasis; Humans; Insulin; Insulin Resistance; Leptin; Male; Middle Aged; Propanolamines; Resistin | 2008 |
The effects of beta-blockers in patients with stable chronic heart failure. Predictors of left ventricular ejection fraction improvement and impact on prognosis.
Topics: Adrenergic beta-Antagonists; Bisoprolol; Carbazoles; Carvedilol; Chronic Disease; Female; Heart Failure; Humans; Male; Middle Aged; Prognosis; Propanolamines; Prospective Studies; Stroke Volume | 2007 |
Does NT-proBNP remain a sensitive biomarker for chronic heart failure after administration of a beta-blocker?
Topics: Adrenergic beta-Antagonists; Biomarkers; Bisoprolol; Carbazoles; Carvedilol; Female; Heart Failure; Humans; Male; Middle Aged; Natriuretic Peptide, Brain; Peptide Fragments; Predictive Value of Tests; Propanolamines; Sensitivity and Specificity; Severity of Illness Index | 2007 |
Comparative dose titration responses to the introduction of bisoprolol or carvedilol in stable chronic systolic heart failure.
Topics: Adrenergic beta-Antagonists; Adult; Aged; Bisoprolol; Blood Pressure; Carbazoles; Carvedilol; Chronic Disease; Female; Heart Failure, Systolic; Heart Rate; Humans; Male; Middle Aged; Propanolamines; Ventricular Dysfunction, Left | 2007 |
Bisoprolol vs. carvedilol in elderly patients with heart failure: rationale and design of the CIBIS-ELD trial.
Topics: Adrenergic beta-Antagonists; Age Distribution; Aged; Bisoprolol; Carbazoles; Carvedilol; Double-Blind Method; Drug Tolerance; Female; Heart Failure; Humans; Male; Propanolamines; Randomized Controlled Trials as Topic; Research Design; Treatment Outcome | 2008 |
The comparative effects of long-term carvedilol versus bisoprolol therapy on QT dispersion in patients with chronic heart failure.
Topics: Adrenergic beta-Antagonists; Aged; Bisoprolol; Carbazoles; Carvedilol; Chronic Disease; Electrocardiography; Female; Follow-Up Studies; Heart Failure; Heart Rate; Humans; Male; Middle Aged; Propanolamines; Stroke Volume | 2009 |
Comparison of the pharmacokinetic properties of bisoprolol and carvedilol in healthy dogs.
Topics: Administration, Oral; Adrenergic beta-Antagonists; Animals; Area Under Curve; Biological Availability; Bisoprolol; Carbazoles; Carvedilol; Cross-Over Studies; Dogs; Half-Life; Injections, Intravenous; Male; Propanolamines | 2008 |
Changes in platelet size and spleen volume in response to selective and non-selective beta-adrenoceptor blockade in hypertensive patients.
Topics: Adrenergic beta-Antagonists; Adult; Antihypertensive Agents; Bisoprolol; Blood Platelets; Carbazoles; Carvedilol; Cell Size; Exercise; Exercise Test; Heart Rate; Humans; Hypertension; Middle Aged; Organ Size; Propanolamines; Rest; Spleen; Substrate Specificity | 2009 |
Beta-blocker treatment of stable heart failure in primary care.
Topics: Adrenergic alpha-Antagonists; Aged; Bisoprolol; Carbazoles; Carvedilol; Female; Heart Failure; Humans; Male; Middle Aged; Primary Health Care; Propanolamines; Prospective Studies | 2009 |
Differences between beta-blockers in patients with chronic heart failure and chronic obstructive pulmonary disease: a randomized crossover trial.
Topics: Adrenergic beta-Antagonists; Adult; Aged; Aged, 80 and over; Bisoprolol; Carbazoles; Carvedilol; Chronic Disease; Cross-Over Studies; Echocardiography; Female; Heart Failure; Humans; Male; Metoprolol; Middle Aged; Natriuretic Peptide, Brain; Propanolamines; Pulmonary Disease, Chronic Obstructive; Pulse; Respiratory Function Tests; Walking | 2010 |
Comparison of effectiveness of carvedilol versus bisoprolol for prevention of postdischarge atrial fibrillation after coronary artery bypass grafting in patients with heart failure.
Topics: Administration, Oral; Adrenergic beta-Antagonists; Aged; Atrial Fibrillation; Bisoprolol; Carbazoles; Carvedilol; Coronary Artery Bypass; Coronary Artery Disease; Dose-Response Relationship, Drug; Electrocardiography; Female; Heart Failure; Humans; Male; Patient Discharge; Propanolamines; Retrospective Studies; Treatment Outcome | 2011 |
Titration to target dose of bisoprolol vs. carvedilol in elderly patients with heart failure: the CIBIS-ELD trial.
Topics: Adrenergic beta-Antagonists; Aged; Bisoprolol; Carbazoles; Carvedilol; Dose-Response Relationship, Drug; Double-Blind Method; Europe; Female; Forced Expiratory Volume; Heart Failure; Heart Rate; Humans; Male; Propanolamines; Treatment Outcome | 2011 |
Self-rated health predicts adverse events during β-blocker treatment: the CIBIS-ELD randomised trial analysis.
Topics: Adrenergic beta-Antagonists; Aged; Bisoprolol; Carbazoles; Carvedilol; Double-Blind Method; Female; Follow-Up Studies; Health Status Indicators; Humans; Male; Predictive Value of Tests; Propanolamines; Self Report; Treatment Outcome | 2013 |
Additive effects of β-blockers on renin-angiotensin system inhibitors for patients after acute myocardial infarction treated with primary coronary revascularization.
Topics: Adrenergic beta-1 Receptor Antagonists; Aged; Aged, 80 and over; Angioplasty, Balloon, Coronary; Angiotensin Receptor Antagonists; Angiotensin-Converting Enzyme Inhibitors; Bisoprolol; Blood Pressure; Carbazoles; Carvedilol; Drug Synergism; Female; Follow-Up Studies; Humans; Male; Middle Aged; Myocardial Infarction; Propanolamines; Renin-Angiotensin System; Retrospective Studies; Time Factors | 2011 |
Differences between bisoprolol and carvedilol in patients with chronic heart failure and chronic obstructive pulmonary disease: a randomized trial.
Topics: Adrenergic beta-Antagonists; Aged; Antihypertensive Agents; Bisoprolol; Carbazoles; Carvedilol; Chronic Disease; Dose-Response Relationship, Drug; Female; Forced Expiratory Volume; Heart Failure; Humans; Male; Maximum Tolerated Dose; Propanolamines; Pulmonary Disease, Chronic Obstructive; Slovenia; Stroke Volume; Treatment Outcome; Ventricular Function, Left | 2011 |
Is target dose the treatment target? Uptitrating beta-blockers for heart failure in the elderly.
Topics: Adrenergic beta-Antagonists; Aged; Aged, 80 and over; Bisoprolol; Blood Pressure; Carbazoles; Carvedilol; Dose-Response Relationship, Drug; Double-Blind Method; Drug Delivery Systems; Female; Heart Failure; Heart Rate; Humans; Male; Propanolamines; Treatment Outcome | 2012 |
Impact of the β1-adrenoceptor Arg389Gly polymorphism on heart-rate responses to bisoprolol and carvedilol in heart-failure patients.
Topics: Adrenergic beta-1 Receptor Antagonists; Aged; Atrial Fibrillation; Bisoprolol; Carbazoles; Carvedilol; Dose-Response Relationship, Drug; Double-Blind Method; Female; Heart Failure; Heart Rate; Humans; Male; Polymorphism, Single Nucleotide; Propanolamines; Receptors, Adrenergic, beta-1; Treatment Outcome | 2012 |
Effect of β-blocker cessation on chronotropic incompetence and exercise tolerance in patients with advanced heart failure.
Topics: Adrenergic beta-Antagonists; Adult; Analysis of Variance; Biomarkers; Bisoprolol; Carbazoles; Carvedilol; Drug Administration Schedule; Exercise Test; Exercise Tolerance; Female; Heart Failure; Heart Rate; Humans; Male; Metoprolol; Middle Aged; New York City; Norepinephrine; Oxygen Consumption; Propanolamines; Prospective Studies; Respiration; Time Factors | 2012 |
Ivabradine improves all aspects of quality of life assessed with the 36-item short form health survey in subjects with chronic ischemic heart disease compared with beta-blockers.
Topics: Adrenergic beta-Antagonists; Aged; Angina, Stable; Atenolol; Benzazepines; Bisoprolol; Carbazoles; Carvedilol; Female; Health Surveys; Humans; Ivabradine; Male; Middle Aged; Propanolamines; Quality of Life | 2013 |
Beta blockers therapy is associated with improved left ventricular systolic function and sustained exercise capacity in elderly patients with heart failure. CIBIS-ELD sub-study.
Topics: Adrenergic beta-Antagonists; Aged; Aging; Bisoprolol; Blood Pressure; Carbazoles; Carvedilol; Exercise Test; Female; Heart Failure; Heart Rate; Humans; Male; Propanolamines; Prospective Studies; Ventricular Function, Left | 2012 |
Further data on beta-blockers and cancer risk: observational study and meta-analysis of randomized clinical trials.
Topics: Adrenergic beta-Antagonists; Aged; Atenolol; Benzopyrans; Bisoprolol; Carbazoles; Carvedilol; Diabetes Mellitus; Ethanolamines; Female; Humans; Insulin; Insulin Glargine; Insulin, Long-Acting; Male; Metformin; Myocardial Ischemia; Nebivolol; Neoplasms; Propanolamines; Risk | 2013 |
Determinants of change in quality of life in the Cardiac Insufficiency Bisoprolol Study in Elderly (CIBIS-ELD).
Topics: Adrenergic beta-1 Receptor Antagonists; Aged; Aged, 80 and over; Bisoprolol; Carbazoles; Carvedilol; Depression; Female; Heart Failure; Humans; Linear Models; Male; Propanolamines; Quality of Life; Surveys and Questionnaires; Treatment Outcome | 2013 |
Multiparametric comparison of CARvedilol, vs. NEbivolol, vs. BIsoprolol in moderate heart failure: the CARNEBI trial.
Topics: Adolescent; Adrenergic beta-Antagonists; Adult; Aged; Aged, 80 and over; Benzopyrans; Bisoprolol; Carbazoles; Carvedilol; Cross-Over Studies; Dose-Response Relationship, Drug; Drug Administration Schedule; Echocardiography; Electrocardiography; Ethanolamines; Female; Heart Failure; Humans; Male; Middle Aged; Nebivolol; Platelet Aggregation Inhibitors; Propanolamines; Severity of Illness Index; Single-Blind Method; Stroke Volume; Surveys and Questionnaires; Treatment Outcome; Ventricular Function, Left; Young Adult | 2013 |
[Effect of monotherapy with nebivolol, bisoprolol, carvedilol on the state of vegetative nervous system and sexual function in men with arterial hypertension].
Topics: Adult; Antihypertensive Agents; Benzopyrans; Bisoprolol; Blood Pressure; Carbazoles; Carvedilol; Drug Monitoring; Erectile Dysfunction; Ethanolamines; Heart Rate; Hemodynamics; Humans; Hypertension; Male; Middle Aged; Nebivolol; Parasympathetic Nervous System; Penile Erection; Penis; Propanolamines; Treatment Outcome | 2013 |
Efficacy and safety of bisoprolol fumarate compared with carvedilol in Japanese patients with chronic heart failure: results of the randomized, controlled, double-blind, Multistep Administration of bisoprolol IN Chronic Heart Failure II (MAIN-CHF II) stud
Topics: Adrenergic beta-Antagonists; Aged; Bisoprolol; Carbazoles; Carvedilol; Chronic Disease; Disease-Free Survival; Double-Blind Method; Drug Administration Schedule; Early Termination of Clinical Trials; Female; Heart Failure; Heart Rate; Humans; Japan; Male; Middle Aged; Patient Admission; Propanolamines; Prospective Studies; Severity of Illness Index; Stroke Volume; Time Factors; Treatment Outcome; Ventricular Function, Left; Ventricular Remodeling | 2014 |
Role of alveolar β2-adrenergic receptors on lung fluid clearance and exercise ventilation in healthy humans.
Topics: Adult; Bisoprolol; Carbazoles; Carvedilol; Exercise; Extracellular Fluid; Humans; Hyperventilation; Lung; Male; Propanolamines; Pulmonary Diffusing Capacity; Receptors, Adrenergic, beta-2; Respiratory Function Tests; Young Adult | 2013 |
Regional differences among female patients with heart failure from the Cardiac Insufficiency BIsoprolol Study in ELDerly (CIBIS-ELD).
Topics: Adrenergic alpha-1 Receptor Antagonists; Adrenergic beta-1 Receptor Antagonists; Aged; Bisoprolol; Carbazoles; Carvedilol; Dose-Response Relationship, Drug; Double-Blind Method; Europe; Female; Heart Failure; Humans; Male; Propanolamines; Risk Factors; Sex Factors; Survival Rate | 2014 |
Ivabradine improves quality of life in subjects with chronic heart failure compared to treatment with β-blockers: results of a multicentric observational APULIA study.
Topics: Adrenergic beta-Antagonists; Aged; Benzazepines; Bisoprolol; Blood Pressure; Carbazoles; Carvedilol; Chronic Disease; Female; Heart Failure; Heart Rate; Humans; Ivabradine; Male; Middle Aged; Propanolamines; Quality of Life; Surveys and Questionnaires; Treatment Outcome | 2013 |
Heart rate following short-term beta-blocker titration predicts all-cause mortality in elderly chronic heart failure patients: insights from the CIBIS-ELD trial.
Topics: Adrenergic beta-Antagonists; Aged; Aged, 80 and over; Bisoprolol; Carbazoles; Carvedilol; Chronic Disease; Dose-Response Relationship, Drug; Female; Heart Failure; Heart Rate; Humans; Male; Mortality; Prognosis; Propanolamines; Proportional Hazards Models; Treatment Outcome | 2014 |
Evaluation of synergistic effects of resynchronization therapy and a β-blocker up-titration strategy based on a predefined patient-management program: the RESTORE study.
Topics: Adrenergic beta-1 Receptor Antagonists; Bisoprolol; Carbazoles; Cardiac Resynchronization Therapy; Carvedilol; Case-Control Studies; Combined Modality Therapy; Defibrillators, Implantable; Drug Synergism; Drug Therapy, Combination; Electrocardiography; Heart Failure; Humans; Propanolamines; Prospective Studies; Research Design; Titrimetry | 2015 |
Effect of Combining Ivabradine and β-Blockers: Focus on the Use of Carvedilol in the SHIFT Population.
Topics: Adrenergic beta-Antagonists; Aged; Benzazepines; Bisoprolol; Carbazoles; Cardiovascular Agents; Carvedilol; Double-Blind Method; Drug Therapy, Combination; Female; Heart Failure, Systolic; Hospitalization; Humans; Ivabradine; Male; Metoprolol; Middle Aged; Nebivolol; Propanolamines; Proportional Hazards Models; Treatment Outcome | 2015 |
Impact of Carvedilol versus β1-selective β blockers (bisoprolol, metoprolol, and nebivolol) in patients with acute myocardial infarction undergoing percutaneous coronary intervention.
Topics: Adrenergic alpha-1 Receptor Antagonists; Adrenergic beta-1 Receptor Antagonists; Bisoprolol; Carbazoles; Carvedilol; Electrocardiography; Female; Follow-Up Studies; Humans; Male; Metoprolol; Middle Aged; Myocardial Infarction; Nebivolol; Percutaneous Coronary Intervention; Preoperative Care; Propanolamines; Prospective Studies; Registries; Republic of Korea; Retrospective Studies; Survival Rate; Treatment Outcome | 2015 |
Association between remote implantable cardioverter defibrillator monitoring and beta-blocker utilization: An analysis from the EFFECT study.
Topics: Adrenergic beta-Antagonists; Aged; Bisoprolol; Carbazoles; Carvedilol; Defibrillators, Implantable; Female; Humans; Male; Medication Adherence; Monitoring, Ambulatory; Propanolamines; Prospective Studies; Telemedicine; Treatment Outcome | 2016 |
Regional differences in health-related quality of life in elderly heart failure patients: results from the CIBIS-ELD trial.
Topics: Adrenergic alpha-1 Receptor Antagonists; Adrenergic beta-1 Receptor Antagonists; Aged; Bisoprolol; Carbazoles; Carvedilol; Dose-Response Relationship, Drug; Double-Blind Method; Female; Health Status; Heart Failure; Humans; Male; Patient Reported Outcome Measures; Propanolamines; Quality of Life; Stroke Volume; Surveys and Questionnaires | 2017 |
Relationship between heart failure, concurrent chronic obstructive pulmonary disease and beta-blocker use: a Danish nationwide cohort study.
Topics: Adrenergic beta-1 Receptor Agonists; Aged; Bisoprolol; Carvedilol; Cause of Death; Comorbidity; Denmark; Drug Therapy, Combination; Female; Follow-Up Studies; Heart Failure; Humans; Male; Metoprolol; Nebivolol; Pulmonary Disease, Chronic Obstructive; Registries; Retrospective Studies; Time Factors; Treatment Outcome | 2018 |
Anti-ß1-Adrenoreceptor auto-Antibodies in elderly heart failure patients.
Topics: Adrenergic beta-Antagonists; Aged; Aged, 80 and over; Autoantibodies; Biomarkers; Bisoprolol; Carvedilol; Enzyme-Linked Immunosorbent Assay; Female; Follow-Up Studies; Glomerular Filtration Rate; Heart Failure; Heart Rate; Humans; Male; Receptors, Adrenergic, beta-1; Treatment Outcome; Ventricular Function, Left | 2019 |
Tolerability, Efficacy, and Safety of Bisoprolol vs. Carvedilol in Japanese Patients With Heart Failure and Reduced Ejection Fraction - The CIBIS-J Trial.
Topics: Adult; Aged; Aged, 80 and over; Bisoprolol; Carvedilol; Heart Failure; Heart Rate; Humans; Japan; Middle Aged; Natriuretic Peptide, Brain; Stroke Volume; Treatment Outcome | 2019 |
Effects of carvedilol vs bisoprolol on inflammation and oxidative stress in patients with chronic heart failure.
Topics: Adrenergic beta-Antagonists; Adult; Aged; Anti-Inflammatory Agents; Bisoprolol; C-Reactive Protein; Carvedilol; Chronic Disease; Female; Heart Failure; Humans; Male; Middle Aged; Oxidative Stress | 2020 |
101 other study(ies) available for carvedilol and bisoprolol
| Article | Year |
|---|---|
QSAR model for drug human oral bioavailability.
Topics: Administration, Oral; Biological Availability; Humans; Models, Biological; Models, Molecular; Pharmaceutical Preparations; Pharmacokinetics; Structure-Activity Relationship | 2000 |
The selectivity of beta-adrenoceptor antagonists at the human beta1, beta2 and beta3 adrenoceptors.
Topics: Adrenergic beta-1 Receptor Agonists; Adrenergic beta-2 Receptor Agonists; Adrenergic beta-3 Receptor Agonists; Adrenergic beta-Agonists; Adrenergic beta-Antagonists; Algorithms; Animals; Cell Line; CHO Cells; Cricetinae; Dioxoles; Humans; Propanolamines; Receptors, Adrenergic, beta-1; Receptors, Adrenergic, beta-2; Receptors, Adrenergic, beta-3 | 2005 |
Assessment of the health effects of chemicals in humans: II. Construction of an adverse effects database for QSAR modeling.
Topics: Adverse Drug Reaction Reporting Systems; Artificial Intelligence; Computers; Databases, Factual; Drug Prescriptions; Drug-Related Side Effects and Adverse Reactions; Endpoint Determination; Models, Molecular; Quantitative Structure-Activity Relationship; Software; United States; United States Food and Drug Administration | 2004 |
High-throughput log P determination by ultraperformance liquid chromatography: a convenient tool for medicinal chemists.
Topics: Chemical Phenomena; Chemistry, Pharmaceutical; Chemistry, Physical; Chromatography, Liquid; Mathematics; Pharmaceutical Preparations; Software | 2008 |
Trend analysis of a database of intravenous pharmacokinetic parameters in humans for 670 drug compounds.
Topics: Blood Proteins; Half-Life; Humans; Hydrogen Bonding; Infusions, Intravenous; Pharmacokinetics; Protein Binding | 2008 |
Lipophilicity of basic drugs measured by hydrophilic interaction chromatography.
Topics: Chemistry, Pharmaceutical; Chromatography; Hydrogen-Ion Concentration; Hydrophobic and Hydrophilic Interactions; Pharmaceutical Preparations; Solubility; Technology, Pharmaceutical | 2009 |
Physicochemical determinants of human renal clearance.
Topics: Humans; Hydrogen Bonding; Hydrogen-Ion Concentration; Hydrophobic and Hydrophilic Interactions; Kidney; Metabolic Clearance Rate; Molecular Weight | 2009 |
Cheminformatics analysis of assertions mined from literature that describe drug-induced liver injury in different species.
Topics: Animals; Chemical and Drug Induced Liver Injury; Cluster Analysis; Databases, Factual; Humans; MEDLINE; Mice; Models, Chemical; Molecular Conformation; Quantitative Structure-Activity Relationship | 2010 |
Physicochemical space for optimum oral bioavailability: contribution of human intestinal absorption and first-pass elimination.
Topics: Administration, Oral; Biological Availability; Humans; Intestinal Absorption; Pharmaceutical Preparations | 2010 |
Comparison of the accuracy of experimental and predicted pKa values of basic and acidic compounds.
Topics: Chemistry, Pharmaceutical; Forecasting; Hydrogen-Ion Concentration; Pharmaceutical Preparations; Random Allocation | 2014 |
Drug repurposing and rediscovery: Design, synthesis and preliminary biological evaluation of 1-arylamino-3-aryloxypropan-2-ols as anti-melanoma agents.
Topics: Antineoplastic Agents; Apoptosis; Cell Proliferation; Cell Survival; Dose-Response Relationship, Drug; Drug Discovery; Drug Repositioning; Drug Screening Assays, Antitumor; Humans; Melanoma; Molecular Docking Simulation; Molecular Structure; Propanols; Skin Neoplasms; Structure-Activity Relationship; Tumor Cells, Cultured | 2020 |
The effects of 2 beta-receptor blocking agents on the microcirculation of healthy subjects and of hypertensive patients.
Topics: Adrenergic beta-Antagonists; Adult; Antihypertensive Agents; Bisoprolol; Blood Pressure; Blood Viscosity; Carbazoles; Carvedilol; Cross-Over Studies; Female; Heart Rate; Hemodynamics; Humans; Hypertension; Male; Microcirculation; Propanolamines; Receptors, Adrenergic, beta-1; Vascular Resistance | 1997 |
[Drugs prescribed for chronic heart failure. Current data on their effectiveness].
Topics: Adrenergic beta-Antagonists; Angiotensin-Converting Enzyme Inhibitors; Antihypertensive Agents; Bisoprolol; Carbazoles; Carvedilol; Chronic Disease; Diuretics; Heart Failure; Humans; Propanolamines | 1998 |
In vitro and in vivo characterization of intrinsic sympathomimetic activity in normal and heart failure rats.
Topics: Adrenergic beta-Agonists; Adrenergic beta-Antagonists; Animals; Animals, Newborn; Bisoprolol; Carbazoles; Carvedilol; Cell Membrane; Cells, Cultured; Cyclic AMP; Decerebrate State; Dose-Response Relationship, Drug; Heart Failure; Heart Rate; Iodocyanopindolol; Ligands; Male; Myocardium; Propanolamines; Radioligand Assay; Rats; Rats, Sprague-Dawley; Xamoterol | 1999 |
[The role of beta-adrenergic blocking agents in treatment of heart failure].
Topics: Adrenergic beta-Antagonists; Bisoprolol; Carbazoles; Carvedilol; Heart Failure; Humans; Metoprolol; Propanolamines | 1999 |
[New milestones in the therapy of chronic heart failure with beta blockers].
Topics: Adrenergic beta-Antagonists; Angiotensin-Converting Enzyme Inhibitors; Bisoprolol; Carbazoles; Cardiomyopathy, Dilated; Carvedilol; Controlled Clinical Trials as Topic; Double-Blind Method; Heart Failure; Humans; Metoprolol; Placebos; Prognosis; Propanolamines; Quality of Life; Randomized Controlled Trials as Topic | 2000 |
Beta-blockers for heart failure.
Topics: Adrenergic beta-Antagonists; Bisoprolol; Bradycardia; Carbazoles; Carvedilol; Heart Failure; Humans; Hypotension; Metoprolol; Propanolamines | 2000 |
Comparison of bisoprolol and carvedilol cardioprotection in a rabbit ischemia and reperfusion model.
Topics: Adrenergic beta-Agonists; Adrenergic beta-Antagonists; Animals; Antioxidants; Bisoprolol; Carbazoles; Cardiovascular Agents; Carvedilol; Creatine Kinase; Disease Models, Animal; Dose-Response Relationship, Drug; Heart Rate; Isoproterenol; Lipid Peroxidation; Male; Membrane Lipids; Myocardial Ischemia; Myocardium; Peroxidase; Propanolamines; Rabbits; Reperfusion Injury; Ventricular Pressure | 2000 |
[Beta-blockers in the treatment of chronic heart failure. How should results of clinical studies be introduced into clinical practice].
Topics: Adrenergic beta-Antagonists; Bisoprolol; Carbazoles; Carvedilol; Heart Failure; Humans; Metoprolol; Propanolamines | 2000 |
[New indications for beta blockers. Cave hypertension focus/heart failure].
Topics: Adrenergic beta-Antagonists; Bisoprolol; Carbazoles; Carvedilol; Dose-Response Relationship, Drug; Drug Administration Schedule; Heart Failure; Humans; Hypertension; Propanolamines | 2000 |
A cost-effectiveness analysis of bisoprolol for heart failure.
Topics: Adrenergic beta-Antagonists; Bisoprolol; Carbazoles; Carvedilol; Cost-Benefit Analysis; Follow-Up Studies; Heart Failure; Humans; Propanolamines; United Kingdom | 2001 |
Nebivolol, bucindolol, metoprolol and carvedilol are devoid of intrinsic sympathomimetic activity in human myocardium.
Topics: Adrenergic beta-Antagonists; Benzopyrans; Binding, Competitive; Bisoprolol; Carbazoles; Carvedilol; Ethanolamines; Female; Guanylyl Imidodiphosphate; Heart Ventricles; Humans; Imidazoles; In Vitro Techniques; Inhibitory Concentration 50; Isoproterenol; Male; Metoprolol; Middle Aged; Myocardial Contraction; Myocardium; Nebivolol; Propanolamines; Substrate Specificity; Sympathetic Nervous System; Sympathomimetics; Thermodynamics | 2001 |
Unique effects of carvedilol on noradrenaline release in the human heart.
Topics: Adrenergic beta-Antagonists; Bisoprolol; Carbazoles; Carvedilol; Dose-Response Relationship, Drug; Heart; Heart Failure; Humans; Metoprolol; Myocardium; Norepinephrine; Propanolamines; Treatment Outcome | 2002 |
Current research on carvedilol in heart failure.
Topics: Adrenergic beta-Antagonists; Bisoprolol; Carbazoles; Carvedilol; Heart Failure; Humans; Metoprolol; Propanolamines | 2002 |
beta-blockers in heart failure--much more than heart rate reduction.
Topics: Adrenergic beta-Antagonists; Basal Metabolism; Bisoprolol; Carbazoles; Carvedilol; Heart Failure; Heart Rate; Humans; Propanolamines | 2002 |
Treatment of chronic heart failure with beta adrenergic blockade beyond controlled clinical trials: the BRING-UP experience.
Topics: Adrenergic beta-Antagonists; Aged; Bisoprolol; Carbazoles; Cardiac Output, Low; Carvedilol; Chronic Disease; Contraindications; Female; Follow-Up Studies; Humans; Male; Metoprolol; Middle Aged; Multivariate Analysis; Professional Practice; Propanolamines; Treatment Outcome | 2003 |
Anti-oxidative properties of beta-blockers and angiotensin-converting enzyme inhibitors in congestive heart failure.
Topics: Adrenergic beta-Antagonists; Aged; Angiotensin-Converting Enzyme Inhibitors; Biomarkers; Bisoprolol; Blood Pressure; Carbazoles; Carvedilol; Endothelium, Vascular; Female; Follow-Up Studies; Heart Failure; Humans; Lipid Peroxides; Lisinopril; Male; Middle Aged; Oxidative Stress; Propanolamines; Prospective Studies; Risk Factors; Treatment Outcome; von Willebrand Factor | 2003 |
Neither carvedilol nor bisoprolol in maximally tolerated doses has any specific advantage in lowering chronic heart failure oxidant stress: implications for beta-blocker selection.
Topics: Adrenergic beta-Antagonists; Adult; Aged; Aged, 80 and over; Biomarkers; Bisoprolol; Carbazoles; Carvedilol; Female; Fibrinogen; Heart Failure; Humans; Lipid Peroxides; Male; Middle Aged; Oxidative Stress; P-Selectin; Propanolamines; Statistics, Nonparametric; Treatment Failure; Vasodilator Agents; von Willebrand Factor | 2003 |
[For the first time beta blockers are in direct comparison With carvedilol weak hearts beat longer].
Topics: Adrenergic alpha-Antagonists; Adrenergic beta-Antagonists; Bisoprolol; Carbazoles; Carvedilol; Double-Blind Method; Follow-Up Studies; Heart Failure; Humans; Metoprolol; Multicenter Studies as Topic; Propanolamines; Randomized Controlled Trials as Topic; Time Factors | 2003 |
In heart failure, all beta-blockers are not necessarily equal.
Topics: Adrenergic beta-Antagonists; Bisoprolol; Carbazoles; Carvedilol; Clinical Trials as Topic; Cost-Benefit Analysis; Female; Heart Failure; Humans; Male; Metoprolol; Middle Aged; Propanolamines | 2003 |
Which beta-blocker for heart failure?
Topics: Adrenergic beta-Antagonists; Bisoprolol; Carbazoles; Carvedilol; Contraindications; Coronary Disease; Evidence-Based Medicine; Heart Failure; Humans; Hypertension; Male; Metoprolol; Middle Aged; Propanolamines; Randomized Controlled Trials as Topic | 2004 |
Activation of capsaicin-sensitive sensory neurons by carvedilol, a nonselective beta-blocker, in spontaneous hypertensive rats.
Topics: Adrenergic alpha-Antagonists; Adrenergic beta-Antagonists; Animals; Bisoprolol; Blood Pressure; Calcitonin Gene-Related Peptide; Capsaicin; Carbazoles; Carvedilol; Cells, Cultured; Drug Interactions; Female; Humans; Hypertension; Kidney; Male; Mice; Neurons, Afferent; Prazosin; Propanolamines; Rats; Rats, Inbred SHR; Rats, Sprague-Dawley; Regional Blood Flow | 2004 |
Do pharmacological differences among beta-blockers affect their clinical efficacy in heart failure?
Topics: Adrenergic beta-Antagonists; Bisoprolol; Carbazoles; Carvedilol; Heart Failure; Humans; Metoprolol; Propanolamines; Randomized Controlled Trials as Topic; Receptors, Adrenergic, beta-1; Receptors, Adrenergic, beta-2 | 2004 |
Beta-blocker-induced quadriparesis.
Topics: Adrenergic beta-Antagonists; Bisoprolol; Carbazoles; Carvedilol; Humans; Male; Middle Aged; Propanolamines; Quadriplegia; Renal Dialysis | 2004 |
Anti-inflammatory medication for atrial fibrillation.
Topics: Adrenergic beta-Antagonists; Anti-Inflammatory Agents; Atrial Fibrillation; Bisoprolol; Carbazoles; Carvedilol; Humans; Propanolamines; Randomized Controlled Trials as Topic | 2004 |
[Correction of baroreflex sensitivity impairment and efficacy of prevention of sudden arrhythmic death in patients with postinfarction left ventricular dysfunction].
Topics: Adrenergic beta-Antagonists; Adult; Aged; Amiodarone; Angiotensin-Converting Enzyme Inhibitors; Anti-Arrhythmia Agents; Antihypertensive Agents; Arrhythmias, Cardiac; Atenolol; Baroreflex; Bisoprolol; Carbazoles; Carvedilol; Data Interpretation, Statistical; Death, Sudden, Cardiac; Drug Therapy, Combination; Echocardiography; Electrocardiography; Female; Humans; Male; Metoprolol; Middle Aged; Myocardial Infarction; Perindopril; Phenylephrine; Propanolamines; Time Factors; Ventricular Dysfunction, Left | 2004 |
Skeletal muscle myofibrillar protein oxidation in heart failure and the protective effect of Carvedilol.
Topics: Adrenergic beta-Antagonists; Animals; Antioxidants; Bisoprolol; Carbazoles; Carvedilol; Heart Failure; Male; Monocrotaline; Muscle Proteins; Muscle, Skeletal; Myofibrils; Oxidation-Reduction; Propanolamines; Rats; Rats, Sprague-Dawley | 2005 |
Association between beta-1 and beta-2 adrenergic receptor gene polymorphisms and the response to beta-blockade in patients with stable congestive heart failure.
Topics: Adrenergic beta-Antagonists; Aged; Alleles; Angiography; Bisoprolol; Carbazoles; Carvedilol; Codon; Down-Regulation; Echocardiography; Female; Gene Frequency; Heart Failure; Humans; Male; Maximum Tolerated Dose; Middle Aged; Polymorphism, Genetic; Propanolamines; Prospective Studies; Receptors, Adrenergic, beta-1; Time Factors; Treatment Outcome; Ventricular Function, Left | 2005 |
The effects of long-term beta-blockade on the ventilatory responses to exercise in chronic heart failure.
Topics: Adrenergic beta-Antagonists; Aged; Bisoprolol; Carbazoles; Carvedilol; Exercise Test; Heart Failure; Hemodynamics; Humans; Middle Aged; Oxygen Consumption; Propanolamines; Respiration; Ultrasonography; Ventricular Function, Left | 2005 |
Beta-blocker treatment before angiotensin-converting enzyme inhibitor therapy in newly diagnosed heart failure.
Topics: Adrenergic beta-Antagonists; Angiotensin-Converting Enzyme Inhibitors; Bisoprolol; Carbazoles; Carvedilol; Drug Administration Schedule; Heart Failure; Humans; Propanolamines | 2005 |
Practical recommendations for the use of ACE inhibitors, beta-blockers, aldosterone antagonists and angiotensin receptor blockers in heart failure: putting guidelines into practice.
Topics: Adrenergic beta-Antagonists; Angiotensin Receptor Antagonists; Angiotensin-Converting Enzyme Inhibitors; Benzimidazoles; Benzopyrans; Biphenyl Compounds; Bisoprolol; Captopril; Carbazoles; Carvedilol; Drug Therapy, Combination; Enalapril; Ethanolamines; Evidence-Based Medicine; Guideline Adherence; Heart Failure; Humans; Indoles; Lisinopril; Metoprolol; Mineralocorticoid Receptor Antagonists; Nebivolol; Practice Guidelines as Topic; Propanolamines; Ramipril; Spironolactone; Stroke Volume; Tetrazoles; Valine; Valsartan | 2005 |
[Use of betablockers in elderly patients with congestive heart failure].
Topics: Adrenergic beta-Antagonists; Age Factors; Aged; Aged, 80 and over; Antihypertensive Agents; Bisoprolol; Carbazoles; Carvedilol; Data Interpretation, Statistical; Female; Heart Failure; Humans; Male; Metoprolol; Propanolamines; Risk Factors; Survival Analysis; Time Factors; Treatment Outcome; Vasodilator Agents | 2006 |
Characterization of beta-adrenoceptor antagonists as substrates and inhibitors of the drug transporter P-glycoprotein.
Topics: Adrenergic beta-Antagonists; ATP Binding Cassette Transporter, Subfamily B, Member 1; Bisoprolol; Caco-2 Cells; Carbazoles; Carvedilol; Cyclosporins; Digoxin; Dose-Response Relationship, Drug; Drug Interactions; Humans; Propanolamines; Propranolol; Time Factors | 2006 |
Simultaneous determination of ten antiarrhythic drugs and a metabolite in human plasma by liquid chromatography--tandem mass spectrometry.
Topics: Amiodarone; Anti-Arrhythmia Agents; Atenolol; Bisoprolol; Carbazoles; Carvedilol; Chromatography, Liquid; Diltiazem; Humans; Metoprolol; Mexiletine; Molecular Structure; Propanolamines; Propranolol; Reproducibility of Results; Sotalol; Tandem Mass Spectrometry; Verapamil | 2007 |
Changing beta-blockers in heart failure: when is a class not a class?
Topics: Adrenergic beta-Antagonists; Atenolol; Bisoprolol; Carbazoles; Carvedilol; Heart; Heart Failure; Humans; Natriuretic Peptide, Brain; Propanolamines | 2008 |
Beta-blockade as first-line therapy in the elderly heart failure patient--the proper approach or asking for trouble?
Topics: Adrenergic beta-Antagonists; Aged; Antihypertensive Agents; Bisoprolol; Carbazoles; Carvedilol; Chronic Disease; Clinical Trials as Topic; Drug Therapy, Combination; Enalapril; Heart Failure; Humans; Professional Practice; Propanolamines | 2008 |
Association between mortality and persistent use of beta blockers and angiotensin-converting enzyme inhibitors in patients with left ventricular systolic dysfunction and coronary artery disease.
Topics: Adrenergic beta-Antagonists; Adult; Aged; Angiotensin-Converting Enzyme Inhibitors; Bisoprolol; Carbazoles; Carvedilol; Comorbidity; Coronary Artery Disease; Female; Humans; Male; Metoprolol; Middle Aged; Propanolamines; Survival Analysis; Ventricular Dysfunction, Left | 2009 |
The effect of beta-blockers on the adaptive immune system in chronic heart failure.
Topics: Adrenergic beta-Antagonists; Aged; Benzopyrans; Bisoprolol; Carbazoles; Carvedilol; Chronic Disease; Cohort Studies; Edetic Acid; Ethanolamines; Female; Flow Cytometry; Heart Failure; HLA-DR Antigens; Humans; Immune System; Male; Middle Aged; Nebivolol; Propanolamines; Prospective Studies; Stroke Volume; T-Lymphocytes, Cytotoxic | 2009 |
Interaction of beta-blockers with the renal uptake transporter OCT2.
Topics: Adrenergic beta-Antagonists; Biological Transport; Bisoprolol; Carbazoles; Carvedilol; Cell Line; Humans; Kidney; Metformin; Metoprolol; Organic Cation Transport Proteins; Organic Cation Transporter 2; Propanolamines; Propranolol | 2009 |
The effectiveness of collaborative medicine reviews in delaying time to next hospitalization for patients with heart failure in the practice setting: results of a cohort study.
Topics: Adrenergic beta-Antagonists; Aged; Aged, 80 and over; Australia; Bisoprolol; Carbazoles; Carvedilol; Community Pharmacy Services; Cooperative Behavior; Databases as Topic; Family Practice; Female; Heart Failure; Hospitalization; House Calls; Humans; Kaplan-Meier Estimate; Male; Metoprolol; Program Evaluation; Propanolamines; Proportional Hazards Models; Referral and Consultation; Retrospective Studies; Risk Assessment; Time Factors; Treatment Outcome; Veterans; Widowhood | 2009 |
Comparative effects of carvedilol vs bisoprolol for severe congestive heart failure.
Topics: Adrenergic beta-Antagonists; Aged; Aged, 80 and over; Atrial Fibrillation; Bisoprolol; Carbazoles; Carvedilol; Disease-Free Survival; Drug Evaluation; Female; Heart Failure; Heart Rate; Humans; Male; Middle Aged; Natriuretic Peptide, Brain; Propanolamines; Retrospective Studies; Survival Rate; Treatment Outcome | 2010 |
Chronotropic incompentence and functional capacity in chronic heart failure: no role of β-blockers and β-blocker dose.
Topics: Adrenergic beta-Antagonists; Aged; Bisoprolol; Carbazoles; Carvedilol; Chronic Disease; Dose-Response Relationship, Drug; Echocardiography; Exercise Test; Exercise Tolerance; Female; Heart Failure; Heart Rate; Humans; Linear Models; Male; Middle Aged; Oxygen Consumption; Propanolamines; Ventricular Function, Left | 2012 |
Effects of beta-blockers on ventilation efficiency in heart failure.
Topics: Adrenergic beta-Antagonists; Bisoprolol; Carbazoles; Carvedilol; Echocardiography; Exercise Test; Female; Follow-Up Studies; Heart Failure; Humans; Male; Middle Aged; Oxygen Consumption; Prognosis; Propanolamines; Pulmonary Ventilation; Retrospective Studies; Stroke Volume; Treatment Outcome; Ventricular Function, Left | 2010 |
Which beta-blocker is most effective in heart failure?
Topics: Adrenergic beta-Antagonists; Animals; Benzopyrans; Bisoprolol; Carbazoles; Carvedilol; Clinical Trials as Topic; Comorbidity; Diabetes Mellitus; Disease Progression; Ethanolamines; Heart Failure; Humans; Lung Diseases, Obstructive; Metoprolol; Myocardial Infarction; Nebivolol; Propanolamines; Treatment Outcome; Ventricular Dysfunction, Left; Ventricular Remodeling | 2010 |
Is overall blockade superior to selective blockade of adrenergic receptor subtypes in suppressing left ventricular remodeling in spontaneously hypertensive rats?
Topics: Adrenergic Antagonists; Animals; Apoptosis; Bisoprolol; Blood Pressure; Carbazoles; Carvedilol; Disease Models, Animal; Heart Rate; Humans; Hypertension; Myocytes, Cardiac; Propanolamines; Propranolol; Rats; Rats, Inbred SHR; Receptors, Adrenergic, alpha-1; Receptors, Adrenergic, beta; Ventricular Remodeling | 2010 |
Combined blockade of β- and α₁-adrenoceptors in left ventricular remodeling induced by hypertension: beneficial or not?
Topics: Adrenergic Antagonists; Animals; Bisoprolol; Carbazoles; Carvedilol; Disease Models, Animal; Humans; Hypertension; Propanolamines; Propranolol; Rats; Rats, Inbred SHR; Receptors, Adrenergic, alpha-1; Receptors, Adrenergic, beta; Ventricular Remodeling | 2010 |
Beta-blocker therapy for patients with acute myocardial infarction. -Implications in the post-successful PCI Era in Japan-.
Topics: Adrenergic beta-1 Receptor Antagonists; Angioplasty, Balloon, Coronary; Angiotensin Receptor Antagonists; Angiotensin-Converting Enzyme Inhibitors; Bisoprolol; Carbazoles; Carvedilol; Female; Humans; Male; Myocardial Infarction; Propanolamines; Renin-Angiotensin System | 2011 |
Carvedilol and its new analogs suppress arrhythmogenic store overload-induced Ca2+ release.
Topics: Action Potentials; Animals; Anti-Arrhythmia Agents; Arrhythmias, Cardiac; Bisoprolol; Calcium; Calcium Channel Blockers; Carbazoles; Carvedilol; Cell Line; Drug Therapy, Combination; Electrocardiography; Gene Knock-In Techniques; Humans; Metoprolol; Mice; Mice, Mutant Strains; Microscopy, Confocal; Mutation, Missense; Propanolamines; Ryanodine Receptor Calcium Release Channel | 2011 |
Beta-blockers for heart failure: why you should use them more.
Topics: Adrenergic alpha-1 Receptor Antagonists; Adrenergic beta-Antagonists; Bisoprolol; Carbazoles; Carvedilol; Clinical Trials as Topic; Evidence-Based Medicine; Heart Failure, Systolic; Humans; Metoprolol; Practice Guidelines as Topic; Propanolamines; Treatment Outcome | 2011 |
Carvedilol for the treatment of benign prostatic hypertrophy in patients with heart failure?
Topics: Adrenergic beta-Antagonists; Aged; Bisoprolol; Carbazoles; Carvedilol; Heart Failure; Humans; Male; Propanolamines; Prostatic Hyperplasia; Urinary Retention | 2011 |
[Elevated augmentation index].
Topics: Anticholesteremic Agents; Antihypertensive Agents; Azetidines; Bisoprolol; Blood Pressure; Carbazoles; Carvedilol; Drug Costs; Drug Substitution; Evidence-Based Medicine; Ezetimibe; Female; Germany; Humans; Hypercholesterolemia; Hypertension; Male; Middle Aged; Propanolamines; Pulse | 2012 |
Beneficial effects of beta-blockers on left ventricular function and cellular energy reserve in patients with heart failure.
Topics: Adenosine Triphosphate; Adrenergic beta-Antagonists; Aged; Bisoprolol; Carbazoles; Carvedilol; Echocardiography; Energy Metabolism; Female; Heart; Heart Failure; Humans; Magnetic Resonance Spectroscopy; Male; Propanolamines; Ventricular Function, Left | 2013 |
Beta blocker use in subjects with type 2 diabetes mellitus and systolic heart failure does not worsen glycaemic control.
Topics: Adrenergic beta-Antagonists; Aged; Aged, 80 and over; Albuminuria; Biomarkers; Bisoprolol; Carbazoles; Carvedilol; Diabetes Mellitus, Type 2; Diabetic Nephropathies; Female; Glomerular Filtration Rate; Glycated Hemoglobin; Heart Failure, Systolic; Hospitals, Teaching; Humans; Hypoglycemic Agents; Lipids; Male; Middle Aged; Propanolamines; Prospective Studies; Time Factors; Treatment Outcome; Victoria | 2012 |
Carvedilol suppresses fatty acid oxidation and stimulates glycolysis in C2C12 cells.
Topics: Adrenergic alpha-1 Receptor Antagonists; Adrenergic beta-Antagonists; Animals; Bisoprolol; Carbazoles; Carvedilol; Cell Line; Epinephrine; Fatty Acids; Glycolysis; Mice; Oxidation-Reduction; Palmitic Acid; Prazosin; Propanolamines; Propranolol; Sympathomimetics | 2012 |
[COPD patients with heart failure: no concern about the beta blocker!].
Topics: Adrenergic Agents; Adrenergic beta-Antagonists; Bisoprolol; Carbazoles; Carvedilol; Comorbidity; Contraindications; Heart Failure; Humans; Propanolamines; Pulmonary Disease, Chronic Obstructive; Receptors, Adrenergic, beta-1 | 2012 |
Switching from carvedilol to bisoprolol ameliorates adverse effects in heart failure patients with dizziness or hypotension.
Topics: Adrenergic beta-Antagonists; Aged; Bisoprolol; Carbazoles; Carvedilol; Dizziness; Dose-Response Relationship, Drug; Drug Substitution; Female; Follow-Up Studies; Heart Failure; Humans; Hypotension; Male; Middle Aged; Propanolamines; Retrospective Studies; Time Factors; Treatment Outcome | 2013 |
[Economic analysis of the treatment of heart failure with beta-blockers].
Topics: Adrenergic beta-Antagonists; Benzopyrans; Bisoprolol; Carbazoles; Carvedilol; Clinical Trials as Topic; Cost-Benefit Analysis; Drug Costs; Ethanolamines; Heart Failure; Hospitalization; Humans; Meta-Analysis as Topic; Metoprolol; Nebivolol; Propanolamines | 2013 |
The large-scale placebo-controlled beta-blocker studies in systolic heart failure revisited: results from CIBIS-II, COPERNICUS and SENIORS-SHF compared with stratified subsets from MERIT-HF.
Topics: Adrenergic beta-Antagonists; Adult; Aged; Benzopyrans; Bisoprolol; Carbazoles; Carvedilol; Delayed-Action Preparations; Ethanolamines; Female; Heart Failure, Systolic; Hospitalization; Humans; Male; Metoprolol; Middle Aged; Nebivolol; Propanolamines; Randomized Controlled Trials as Topic; Risk; Severity of Illness Index; Stroke Volume; Treatment Outcome | 2014 |
Weaning from inotropic support and concomitant beta-blocker therapy in severely ill heart failure patients: take the time in order to improve prognosis.
Topics: Adrenergic beta-Antagonists; Adult; Bisoprolol; Carbazoles; Cardiotonic Agents; Carvedilol; Dobutamine; Echocardiography; Enoximone; Female; Heart Failure; Heart Transplantation; Humans; Male; Middle Aged; Prognosis; Propanolamines; Retrospective Studies; Survival Rate; Ventilator Weaning | 2014 |
Clinical impact of bisoprolol versus carvedilol in patients undergoing femoropopliteal stenting.
Topics: Adrenergic beta-1 Receptor Antagonists; Aged; Bisoprolol; Carbazoles; Carvedilol; Female; Femoral Artery; Follow-Up Studies; Humans; Japan; Male; Peripheral Arterial Disease; Popliteal Artery; Propanolamines; Prospective Studies; Retrospective Studies; Stents; Treatment Outcome | 2014 |
Evaluation of global circumferential strain as prognostic marker after administration of β-blockers for dilated cardiomyopathy.
Topics: Adrenergic beta-Antagonists; Adult; Aged; Area Under Curve; Bisoprolol; Carbazoles; Cardiomyopathy, Dilated; Carvedilol; Chi-Square Distribution; Disease-Free Survival; Echocardiography, Doppler, Color; Echocardiography, Doppler, Pulsed; Female; Humans; Kaplan-Meier Estimate; Logistic Models; Male; Middle Aged; Multivariate Analysis; Myocardial Contraction; Odds Ratio; Predictive Value of Tests; Propanolamines; Recovery of Function; Retrospective Studies; Risk Factors; ROC Curve; Stroke Volume; Time Factors; Treatment Outcome; Ventricular Dysfunction, Left; Ventricular Function, Left; Ventricular Remodeling | 2014 |
Beta-blocker therapy and prognosis of heart failure patients with new-onset diabetes mellitus.
Topics: Adrenergic alpha-1 Receptor Antagonists; Aged; Bisoprolol; Carbazoles; Carvedilol; Case-Control Studies; Diabetes Mellitus, Type 2; Female; Heart Failure; Humans; Male; Prognosis; Propanolamines; Prospective Studies; Severity of Illness Index; Spain | 2015 |
Impact of β-blocker selectivity on long-term outcomes in congestive heart failure patients with chronic obstructive pulmonary disease.
Topics: Adrenergic alpha-1 Receptor Antagonists; Aged; Aged, 80 and over; Bisoprolol; Carbazoles; Carvedilol; Disease Progression; Disease-Free Survival; Female; Heart Failure; Humans; Japan; Kaplan-Meier Estimate; Male; Multivariate Analysis; Patient Readmission; Propanolamines; Proportional Hazards Models; Pulmonary Disease, Chronic Obstructive; Retrospective Studies; Risk Assessment; Risk Factors; Time Factors; Treatment Outcome | 2015 |
Influence of Different β-Blockers on Platelet Aggregation in Patients With Coronary Artery Disease on Dual Antiplatelet Therapy.
Topics: Adrenergic alpha-1 Receptor Antagonists; Aged; Aspirin; Bisoprolol; Carbazoles; Carvedilol; Clopidogrel; Coronary Artery Disease; Drug Interactions; Drug Therapy, Combination; Female; Humans; Male; Metoprolol; Middle Aged; Nebivolol; Platelet Aggregation; Platelet Aggregation Inhibitors; Platelet Function Tests; Propanolamines; Prospective Studies; Ticlopidine; Treatment Outcome | 2016 |
[The comparative effectiveness of beta-blockers and inhibitors of if-iodium using in patients with stable angina pectoris].
Topics: Adrenergic beta-Antagonists; Angina, Stable; Benzazepines; Bisoprolol; Carbazoles; Carvedilol; Electrocardiography; Female; Heart Rate; Humans; Ivabradine; Male; Middle Aged; Myocardial Ischemia; Propanolamines | 2015 |
Carvedilol Suppresses Apoptosis and Ion Channel Remodelling of HL-1 Cardiac Myocytes Expressing E334K cMyBPC.
Topics: Apoptosis; bcl-2-Associated X Protein; Bisoprolol; Carbazoles; Carrier Proteins; Carvedilol; Cell Line; Humans; Ion Channels; Myocytes, Cardiac; Propanolamines; Proto-Oncogene Proteins c-bcl-2; Tumor Suppressor Protein p53 | 2016 |
Prognostic Benefits of Carvedilol, Bisoprolol, and Metoprolol Controlled Release/Extended Release in Hemodialysis Patients with Heart Failure: A 10-Year Cohort.
Topics: Adrenergic beta-Antagonists; Adult; Aged; Angiotensin II Type 1 Receptor Blockers; Angiotensin-Converting Enzyme Inhibitors; Bisoprolol; Carbazoles; Carvedilol; Chi-Square Distribution; Databases, Factual; Delayed-Action Preparations; Drug Compounding; Female; Heart Failure; Humans; Kaplan-Meier Estimate; Kidney Failure, Chronic; Male; Metoprolol; Middle Aged; Multivariate Analysis; Propanolamines; Propensity Score; Proportional Hazards Models; Renal Dialysis; Retrospective Studies; Risk Factors; Taiwan; Time Factors; Treatment Outcome | 2016 |
Carvedilol, Bisoprolol, and Metoprolol Use in Patients With Coexistent Heart Failure and Chronic Obstructive Pulmonary Disease.
Topics: Adrenergic beta-Antagonists; Adult; Aged; Aged, 80 and over; Bisoprolol; Carbazoles; Carvedilol; Contraindications; Female; Heart Failure; Humans; Male; Metoprolol; Middle Aged; Propanolamines; Pulmonary Disease, Chronic Obstructive; Retrospective Studies; Taiwan; Young Adult | 2016 |
BETAWIN-AHF study: effect of beta-blocker withdrawal during acute decompensation in patients with chronic heart failure.
Topics: Adrenergic beta-Antagonists; Aged; Aged, 80 and over; Bisoprolol; Carbazoles; Carvedilol; Chi-Square Distribution; Chronic Disease; Drug Administration Schedule; Emergency Service, Hospital; Female; Heart Failure; Hospital Mortality; Humans; Logistic Models; Male; Multivariate Analysis; Odds Ratio; Propanolamines; Registries; Risk Factors; Spain; Time Factors; Treatment Outcome | 2016 |
Older adults with heart failure treated with carvedilol, bisoprolol, or metoprolol tartrate: risk of mortality.
Topics: Adrenergic beta-Antagonists; Aged; Bisoprolol; Carbazoles; Carvedilol; Cohort Studies; Databases, Factual; Female; Follow-Up Studies; Heart Failure; Hospitalization; Humans; Male; Metoprolol; Propanolamines; Propensity Score; Proportional Hazards Models; Quebec; Treatment Outcome | 2017 |
Evaluating the effectiveness of different beta-adrenoceptor blockers in heart failure patients.
Topics: Adrenergic beta-Antagonists; Aged; Aged, 80 and over; Bisoprolol; Carbazoles; Carvedilol; Female; Heart Failure; Hospitalization; Humans; Male; Metoprolol; Middle Aged; Propanolamines; Propensity Score; Proportional Hazards Models; Retrospective Studies; Taiwan; Treatment Outcome | 2017 |
Impact of Beta-Blocker Initiation Timing on Mortality Risk in Patients With Diabetes Mellitus Undergoing Noncardiac Surgery: A Nationwide Population-Based Cohort Study.
Topics: Adrenergic beta-Antagonists; Aged; Atenolol; Bisoprolol; Carbazoles; Carvedilol; Cohort Studies; Databases, Factual; Diabetes Mellitus, Type 2; Female; Hospital Mortality; Humans; Male; Metoprolol; Middle Aged; Mortality; Odds Ratio; Perioperative Care; Propanolamines; Propensity Score; Protective Factors; Risk Factors; Surgical Procedures, Operative; Taiwan; Time Factors | 2017 |
Influence of Peroxide Impurities in Povidone on the Stability of Selected β-Blockers with the Help of HPLC.
Topics: Adrenergic beta-Antagonists; Atenolol; Bisoprolol; Carbazoles; Carvedilol; Chromatography, High Pressure Liquid; Drug Contamination; Drug Stability; Excipients; Metoprolol; Oxidation-Reduction; Peroxides; Povidone; Propanolamines | 2017 |
Bisoprolol compared with carvedilol and metoprolol succinate in the treatment of patients with chronic heart failure.
Topics: Adrenergic beta-1 Receptor Antagonists; Aged; Aged, 80 and over; Bisoprolol; Carbazoles; Carvedilol; Chronic Disease; England; Female; Follow-Up Studies; Germany; Heart Failure; Humans; Male; Metoprolol; Middle Aged; Norway; Propanolamines; Registries; Treatment Outcome | 2017 |
Analysis of Clinical Efficacy and Adverse Effects of β-Blocking Agents Used Clinically for Chronic Heart Failure.
Topics: Adrenergic beta-Antagonists; Bisoprolol; Carbazoles; Carvedilol; Chronic Disease; Forced Expiratory Volume; Heart Failure; Heart Rate; Humans; Metoprolol; Models, Biological; Propanolamines; Treatment Outcome; Ventricular Function, Left | 2017 |
Development of liquid chromatographic methods for enantioseparation and sensitive detection of β-adrenolytics/β2-agonists in human plasma using a single enantiomer reagent.
Topics: Adrenergic beta-2 Receptor Agonists; Adrenergic beta-Antagonists; Albuterol; Bisoprolol; Carbazoles; Carvedilol; Chromatography, High Pressure Liquid; Humans; Limit of Detection; Linear Models; Naproxen; Propanolamines; Reproducibility of Results; Stereoisomerism; Triazoles | 2017 |
The evaluation of β-adrenoceptor blocking agents in patients with COPD and congestive heart failure: a nationwide study.
Topics: Adrenergic beta-Antagonists; Aged; Aged, 80 and over; Bisoprolol; Carbazoles; Carvedilol; Chi-Square Distribution; Databases, Factual; Disease Progression; Female; Heart Failure; Hospitalization; Humans; Male; Metoprolol; Middle Aged; Propanolamines; Propensity Score; Proportional Hazards Models; Pulmonary Disease, Chronic Obstructive; Retrospective Studies; Taiwan; Time Factors; Treatment Outcome | 2017 |
The mortality benefit of carvedilol versus bisoprolol in patients with heart failure with reduced ejection fraction.
Topics: Adrenergic beta-1 Receptor Antagonists; Aged; Aged, 80 and over; Bisoprolol; Carvedilol; Female; Heart Failure; Humans; Male; Middle Aged; Prospective Studies; Recovery of Function; Registries; Republic of Korea; Risk Assessment; Risk Factors; Stroke Volume; Time Factors; Treatment Outcome; Ventricular Function, Left | 2019 |
Low Utilization of Beta-Blockers Among Medicare Beneficiaries Hospitalized for Heart Failure With Reduced Ejection Fraction.
Topics: Adrenergic beta-1 Receptor Antagonists; Aged; Bisoprolol; Carvedilol; Cohort Studies; Drug Prescriptions; Female; Heart Failure; Humans; Male; Medicare Part D; Medication Adherence; Metoprolol; Retrospective Studies; Stroke Volume; United States | 2019 |
β-Blockers and 1-Year Postdischarge Mortality for Heart Failure and Reduced Ejection Fraction and Slow Discharge Heart Rate.
Topics: Adrenergic beta-Antagonists; Aged; Bisoprolol; Carvedilol; Female; Follow-Up Studies; Heart Failure; Heart Rate; Humans; Male; Metoprolol; Nebivolol; Patient Discharge; Prospective Studies; Republic of Korea; Stroke Volume; Survival Rate; Time Factors; Treatment Outcome | 2019 |
Beta-blocker choice and exchangeability in patients with heart failure and chronic obstructive pulmonary disease: an Italian register-based cohort study.
Topics: Adrenergic beta-Antagonists; Aged; Aged, 80 and over; Atrioventricular Block; Bisoprolol; Carvedilol; Cerebrovascular Disorders; Cohort Studies; Comorbidity; Drug Prescriptions; Drug Substitution; Drug Utilization; Female; Heart Failure; Hospitalization; Humans; Italy; Male; Metoprolol; Nebivolol; Practice Guidelines as Topic; Pulmonary Disease, Chronic Obstructive; Registries; Renal Insufficiency, Chronic; Retrospective Studies; Thrombosis | 2019 |
High-throughput quantification of ten antiarrhythmic drugs in human plasma using UPLC-MS/MS.
Topics: Anti-Arrhythmia Agents; Atenolol; Bisoprolol; Carvedilol; Chromatography, High Pressure Liquid; Diltiazem; Flecainide; High-Throughput Screening Assays; Humans; Lidocaine; Metoprolol; Propranolol; Reproducibility of Results; Sotalol; Spectrometry, Mass, Electrospray Ionization; Tandem Mass Spectrometry; Verapamil | 2019 |
β-Blocker Use and Risk of Mortality in Heart Failure Patients Initiating Maintenance Dialysis.
Topics: Adrenergic beta-Antagonists; Aged; Aged, 80 and over; Atenolol; Bisoprolol; Carvedilol; Cause of Death; Cohort Studies; Female; Heart Failure; Hospitalization; Humans; Kidney Failure, Chronic; Labetalol; Logistic Models; Male; Metoprolol; Middle Aged; Mortality; Nadolol; Proportional Hazards Models; Propranolol; Protective Factors; Renal Dialysis; Retrospective Studies; Risk; Risk Factors | 2021 |
Beta-blockers utilization in heart failure patients: Sub-analysis of a nation-wide population-based study in the Czech Republic.
Topics: Adrenergic beta-Antagonists; Betaxolol; Bisoprolol; Carbazoles; Carvedilol; Czech Republic; Heart Failure; Humans; Metoprolol; Nebivolol; Propanolamines; Retrospective Studies | 2021 |
Performance of a cardiac lipid panel compared to four prognostic scores in chronic heart failure.
Topics: Adrenergic beta-1 Receptor Antagonists; Aged; Biomarkers; Bisoprolol; Carvedilol; Cluster Analysis; Female; Heart Disease Risk Factors; Heart Failure; Humans; Lipidomics; Male; Multicenter Studies as Topic; Natriuretic Peptide, Brain; Peptide Fragments; Prognosis; Proof of Concept Study; Randomized Controlled Trials as Topic; Regression Analysis; Survival Analysis; Treatment Outcome | 2021 |
Contraindications Differ Widely Among Beta Blockers and Ought to be Cited for an Individual Drug, Not for the Entire Class.
Topics: Adrenergic beta-Antagonists; Bisoprolol; Carvedilol; Contraindications; Heart Failure; Humans; Nebivolol | 2021 |
The double anaerobic threshold in heart failure.
Topics: Adrenergic beta-Antagonists; Anaerobic Threshold; Bisoprolol; Carvedilol; Exercise Test; Heart Failure; Humans; Oxygen; Oxygen Consumption | 2022 |
[Transudative chylothorax complicated with liver cirrhosis due to primary biliary cholangitis:case report].
Topics: Aged; Bisoprolol; Carvedilol; Chylothorax; Dyspnea; Female; Heart Failure; Humans; Hypertension, Portal; Liver Cirrhosis; Liver Cirrhosis, Biliary; Pleural Effusion | 2022 |
Guideline-Directed Medical Therapy in Newly Diagnosed Heart Failure With Reduced Ejection Fraction in the Community.
Topics: Adrenergic beta-Antagonists; Aged; Angiotensin Receptor Antagonists; Angiotensin-Converting Enzyme Inhibitors; Bisoprolol; Carvedilol; Female; Heart Failure; Humans; Male; Metoprolol; Mineralocorticoid Receptor Antagonists; Neprilysin; Receptors, Angiotensin; Retrospective Studies; Stroke Volume; Treatment Outcome | 2022 |
Potential Interaction between Sodium Polystyrene Sulfonate and Prescription Drugs in Artificial Intestinal Juice.
Topics: Atorvastatin; Bisoprolol; Carvedilol; Potassium; Prescription Drugs | 2023 |
Differential Effects of the Betablockers Carvedilol, Metoprolol and Bisoprolol on Cardiac K
Topics: Bisoprolol; Carvedilol; Heart; Heart Failure; Humans; Metoprolol; Protein Isoforms | 2023 |